227 results on '"T Mom"'
Search Results
2. Neuropatías auditivas
- Author
-
T. Mom, M. Puechmaille, O. Plainfossé, N. Saroul, L. Gilain, and P. Avan
- Subjects
General Medicine - Published
- 2022
- Full Text
- View/download PDF
3. Recommandations pour la réalisation d’examen IRM chez les patients porteurs d’implant cochléaire
- Author
-
J. Colamarino, B. Claise, T. Mom, L. Boyer, and S. Mirafzal
- Published
- 2022
- Full Text
- View/download PDF
4. Injected 3T-3D-FLAIR-MRI labyrinthine patterns match with the severity and tonotopic alteration in sudden sensorineural hearing loss
- Author
-
L. Compagnone, V. Levigne, B. Pereira, L. Boyer, T. Mom, and S. Mirafzal
- Subjects
Otorhinolaryngology ,General Medicine - Published
- 2022
- Full Text
- View/download PDF
5. Recommandations de la Société française d’ORL et de chirurgie de la face et du cou (SFORL) et de la Société française d’audiologie (SFA) pour la pratique de l’audiométrie vocale dans le bruit chez l’adulte
- Author
-
C.-A. Joly, P. Reynard, K. Mezzi, D. Bakhos, F. Bergeron, D. Bonnard, S. Borel, D. Bouccara, A. Coez, F. Dejean, M. Del Rio, F. Leclercq, P. Henrion, M. Marx, T. Mom, I. Mosnier, M. Potier, C. Renard, T. Roy, F. Sterkers-Artières, F. Venail, P. Verheyden, E. Veuillet, C. Vincent, and H. Thai-Van
- Subjects
Otorhinolaryngology ,Surgery - Published
- 2022
- Full Text
- View/download PDF
6. Guidelines of the French Society of Otorhinolaryngology-Head and Neck Surgery (SFORL) and the French Society of Audiology (SFA) for Speech-in-Noise Testing in Adults
- Author
-
F. Sterkers-Artières, P. Reynard, F. Dejean, M. Potier, F. Leclercq, A. Coez, K. Mezzi, M. Del Rio, C. Renard, T. Roy, P. Verheyden, Christophe Vincent, Hung Thai-Van, Evelyne Veuillet, D. Bonnard, Isabelle Mosnier, David Bakhos, M. Marx, C.-A. Joly, François Bergeron, Stéphanie Borel, P. Henrion, T. Mom, Didier Bouccara, and Frédéric Venail
- Subjects
Hearing aid ,medicine.medical_specialty ,Modalities ,business.industry ,Hearing loss ,medicine.medical_treatment ,media_common.quotation_subject ,Audiology ,03 medical and health sciences ,Noise ,0302 clinical medicine ,Otorhinolaryngology ,030220 oncology & carcinogenesis ,Cochlear implant ,Perception ,Medicine ,Surgery ,Loudspeaker ,medicine.symptom ,030223 otorhinolaryngology ,business ,media_common - Abstract
Objectives This document presents the fundamentals of speech audiometry in noise, general requirements for implementation and criteria for choice among the tests available in French according to the health-professional's needs. Material and methods The recommendations are based on a systematic analysis of the literature carried out by a multidisciplinary group of doctors, audiologists and audioprosthetists from all over France. They are graded A, B, C or expert opinion according to decreasing level of scientific evidence. Results Eight tests of speech audiometry in noise can be used in France. Conclusion To be complete, evaluation of hearing status requires testing understanding of speech in noise. The examination must begin with a minimum of two measurements familiarizing the subject with the test procedure. For initial diagnosis, adaptive procedures establishing the 50% speech reception threshold (SRT50) in noise are to be preferred in order to obtain a rapid and standardized measurement of perception of speech in noise. When the aim is to measure real-life speech comprehension, tests based on sentences, cocktail-party noise and free-field stimulation are to be preferred. Prosthetic gain is evaluated exclusively in free field. This is the only way to evaluate the contribution of binaurality and to measure perception in noise in an environment as close as possible to real life. In order to avoid acoustic interference in free field, at least five loudspeakers should be used, in particular for evaluating the effectiveness of directional microphones, CROS devices enabling sounds picked up in the damaged ear to be rerouted to the functional ear, or bimodal fitting (i.e., when hearing is enabled by two modalities: for example, hearing aid for one ear, cochlear implant for the other).
- Published
- 2022
- Full Text
- View/download PDF
7. Rinosinusite acuta
- Author
-
N. Saroul, F. Casanova, L. Montrieul, C. Daveau, J. Becaud, T. Mom, L. Gilain, and M. Fieux
- Subjects
General Medicine - Published
- 2021
- Full Text
- View/download PDF
8. Meatoplastias
- Author
-
M. Puechmaille, N. Saroul, A. Dissard, A. Houette, L. Gilain, and T. Mom
- Subjects
General Medicine - Published
- 2021
- Full Text
- View/download PDF
9. Cirugía de las exostosis del conducto auditivo externo
- Author
-
M Puechmaille, Nicolas Saroul, A Dissard, Laurent Gilain, T Mom, and A. Houette
- Subjects
General Medicine - Abstract
Resumen Las exostosis del conducto auditivo externo (CAE) afectan esencialmente a las personas que practican de forma intensiva deportes nauticos. Las indicaciones quirurgicas se basan en la sintomatologia del paciente, la repeticion de las otitis y la repercusion audiometrica. El estudio preoperatorio de las pruebas de imagen es esencial para limitar los riesgos y las complicaciones. La cirugia requiere un fresado prudente de las exostosis despues de la movilizacion de colgajos cutaneos. Esto se puede realizar segun la tecnica de la «cascara de huevo» o por fresado de medial a lateral. Tambien se puede efectuar una reseccion mediante osteotomos. Las complicaciones son infrecuentes. Se trata esencialmente de traumatismos timpanoosiculares o de trastornos de cicatrizacion postoperatorios. En la mayoria de los casos, la cirugia de las exostosis del CAE permite mejorar la calidad de vida de los pacientes, asi como la audiometria tonal postoperatoria en los casos en los que la indicacion corresponda a una sordera.
- Published
- 2021
- Full Text
- View/download PDF
10. Meatoplastiche
- Author
-
M. Puechmaille, N. Saroul, A. Dissard, A. Houette, L. Gilain, and T. Mom
- Published
- 2020
- Full Text
- View/download PDF
11. Injected 3T-3D-FLAIR-MRI labyrinthine patterns match with the severity and tonotopic alteration in sudden sensorineural hearing loss
- Author
-
L, Compagnone, V, Levigne, B, Pereira, L, Boyer, T, Mom, and S, Mirafzal
- Subjects
Adult ,Male ,Imaging, Three-Dimensional ,Hearing Loss, Sensorineural ,Humans ,Female ,Prospective Studies ,Vestibule, Labyrinth ,Hearing Loss, Sudden ,Middle Aged ,Magnetic Resonance Imaging ,Aged - Abstract
The aim of the study was to assess a correlation between MRI labyrinthine changes detected with IV-gadolinium optimized high-resolution 3D-FLAIR sequences 4 h after injection (OPT4-3DFLAIR) and the type of SSNHL, in terms of frequency alteration and severity.This was a prospective monocentric study achieved from July 2019 to December 2020. The inclusion criterion was acute hearing loss of at least 30 dB over three contiguous frequencies occurring within a 72-h period, documented by a pure-tone audiometry (PTA). The primary endpoint was the visual assessment of hyperintensity in labyrinthine structures on OPT4-3DFLAIR performed on 3T MRI.Thirty-six affected ears were included (20 men, 15 women; mean age: 54.5 ± 16.3 years) with 69.4% full-spectrum hearing loss. The median hearing loss, expressed as median and interquartile range [IQR] was 91 dB [74-120], with 47.2% of concomitant acute vestibular syndrome. Pathological signal was found in 26 out of 36 ears (72.2%). Basal turn enhancement was found in all abnormal MRIs, with 73.1% of apical turn enhancement and 50% of vestibular enhancement. Seventeen on 19 cases (89.5%) with apical involvement on MRI had low-frequency hearing loss. Vestibular involvement on MRI was significantly associated with a wider frequency range of hearing loss (p = 0.0002) and the severity of SSNHL (84.5 [71.7-92.5] dB versus 120 [85.8-120] dB, p = 0.0158).This report shows that in pathological MRI in SSNHL, a pathologic cochlear base signal is always detected, a cochlear apical turn enhancement matches with low-tone impairment, and a pathological signal within the posterior labyrinth is associated with an impairment of all frequencies and the severity of SSNHL.
- Published
- 2021
12. Mucoepidermoid carcinoma of salivary glands: A French Network of Rare Head and Neck Tumors (REFCOR) prospective study of 292 cases
- Author
-
A. Varoquaux, L. Castillo, M. Tassart, R. Jankowski, Emmanuelle Uro-Coste, F. Massip, L. Brugel, S Testelin, René-Jean Bensadoun, Olivier Mauvais, C. Bach, P. Herman, Christian-Adrien Righini, Laurent Gilain, Xavier Dufour, T. Mom, L. Laccoureye, E. Baudin, Justin Michel, Ludovic Le Taillandier de Gabory, G. Moulin, D. de Raucourt, C. Ferron, Juliette Thariat, R. Breheret, J.-M. Badet, V. Darrouzet, Bruno Devauchelle, T. Radulesco, Bertrand Baujat, V. Strunski, G. Poissonnet, Thomas Radulesco, Jean-Claude Merol, Renaud Garrel, C. Borel, A. Cosmidis, Odile Casiraghi, Dominique Chevalier, E. Serrano, Caroline Even, J.-C. Merol, P. Demez, L. Geoffrois, N. Fakhry, J.-P. Lavieille, A. Banal, J. Lacau St Guily, S. Duflo, J.-P. Bessède, B. Baujat, Marie Christine Kaminsky, F. Chabolle, Sebastien Albert, Roch Giorgi, O. Sterkers, N. Sarroul, Vianney Bastit, D. Blanchard, P. Lang, E. de Monès, P. Breton, G. Dolivet, R. Garrel, Sébastien Vergez, B. Toussaint, Anne Sudaka, A. Giovanni, G. Noel, P. Hofman, A. Bozorg-Grayeli, O. Malard, M. Housset, E. Lartigau, P. Ceruse, Valérie Costes-Martineau, C. Bertolus, Cécile Badoual, G. Andry, T. Van den Abbeele, F. Kolb, S. Faivre, F. Floret, P. Dessi, M. Juliéron, Nicolas Fakhry, J. Michel, Louis Crampette, Francois Mouawad, O. Choussy, Philippe Schultz, S. Hans, Marine Lefevre, L. Gilain, Emile Reyt, Sylvain Morinière, Philippe Herman, G. Valette, Béatrix Barry, A. Timochenko, Gilles Poissonnet, Antoine Moya-Plana, F. Veillon, S. Vergez, A. Coste, Franck Jegoux, E. Cassagnau, Christine Bach, Y. Marie Robin, B. Guerrier, E. Uro Coste, X. Leroy, Valérie Costes, Olivier Malard, F. Rolland, F. Dubrulle, A.C. Baglin, L. de Gabory, B. Ruhin, A. Girod, G. Calais, Laurie Saloner Dahan, Emmanuel Babin, J.C. Chobaut, Michel Wassef, Benjamin Lallemant, Jean-Michel Prades, C.-A. Righini, Hôpital de la Conception [CHU - APHM] (LA CONCEPTION), Aix Marseille Université (AMU), Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital de la Timone [CHU - APHM] (TIMONE), Biostatistique et technologies de l'information et de la communication (BioSTIC) - [Hôpital de la Timone - APHM] (BiosTIC ), Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), CHU Toulouse [Toulouse], CHU Bordeaux [Bordeaux], CHU Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA), Institut Universitaire de la Face et du Cou [Nice], Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Centre hospitalier universitaire de Nantes (CHU Nantes), Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM), AP-HP - Hôpital Bichat - Claude Bernard [Paris], Hôpital Foch [Suresnes], CHU Lille, Centre Hospitalier Universitaire de Reims (CHU Reims), Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU), CHU Clermont-Ferrand, Centre hospitalier universitaire de Poitiers (CHU Poitiers), Centre Hospitalier Universitaire [Grenoble] (CHU), Institut Gustave Roussy (IGR), Département de cancérologie cervico-faciale [Gustave Roussy] (CCF), CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Sorbonne Université (SU), REFCOR members: S Albert, G Andry, E Babin, C Bach, J-M Badet, C Badoual, A C Baglin, A Banal, B Barry, E Baudin, B Baujat, R J Bensadoun, C Bertolus, J-P Bessède, D Blanchard, C Borel, A Bozorg-Grayeli, R Breheret, P Breton, L Brugel, G Calais, O Casiraghi, E Cassagnau, L Castillo, P Ceruse, F Chabolle, D Chevalier, J C Chobaut, O Choussy, A Cosmidis, A Coste, V Costes, L Crampette, V Darrouzet, P Demez, P Dessi, B Devauchelle, G Dolivet, F Dubrulle, S Duflo, X Dufour, S Faivre, N Fakhry, C Ferron, F Floret, L de Gabory, R Garrel, L Geoffrois, L Gilain, A Giovanni, A Girod, B Guerrier, S Hans, P Herman, P Hofman, M Housset, R Jankowski, F Jegoux, M Juliéron, M-C Kaminsky, F Kolb, J Lacau St Guily, L Laccoureye, B Lallemant, P Lang, E Lartigau, J-P Lavieille, M Lefevre, X Leroy, O Malard, F Massip, O Mauvais, J-C Merol, J Michel, T Mom, S Morinière, E de Monès, G Moulin, G Noel, G Poissonnet, J-M Prades, T Radulesco, D de Raucourt, E Reyt, C Righini, Y Marie Robin, F Rolland, B Ruhin, N Sarroul, P Schultz, E Serrano, O Sterkers, V Strunski, A Sudaka, M Tassart, S Testelin, J Thariat, A Timochenko, B Toussaint, E Uro Coste, G Valette, T Van den Abbeele, A Varoquaux, F Veillon, S Vergez, M Wassef, Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Equipe IFTIM [ImViA - EA7535], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon)-Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER-UNICANCER-Imagerie et Vision Artificielle [Dijon] (ImViA), Université de Bourgogne (UB)-Université de Bourgogne (UB), Laboratoire Parole et Langage (LPL), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), dormoy, valerian, Pathogénèse et contrôle des infections chroniques (PCCI), and Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre Hospitalier Universitaire de Montpellier (CHU Montpellier )
- Subjects
medicine.medical_specialty ,Multivariate analysis ,[SDV]Life Sciences [q-bio] ,Salivary glands ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Mucoepidermoid carcinoma ,Internal medicine ,Diabetes mellitus ,Medicine ,Stage (cooking) ,Intermediate Grade ,030223 otorhinolaryngology ,Prospective cohort study ,ComputingMilieux_MISCELLANEOUS ,Cancer ,[PHYS]Physics [physics] ,business.industry ,General Medicine ,medicine.disease ,3. Good health ,Parotid gland ,[SDV] Life Sciences [q-bio] ,medicine.anatomical_structure ,Oncology ,030220 oncology & carcinogenesis ,Surgery ,business - Abstract
International audience; Background: To describe the characteristics of the largest European study of MEC of salivary glands and to determine the prognostic factors for overall and disease free survival.Patients and methods: Patients with MEC were prospectively included in the Réseau d'Expertise Français sur les Cancers ORL Rares (REFCOR, French Network of Rare Head and Neck Tumors) database between 2009 and 2015.Results: A total of 292 patients were included. Tumors were classified as low grade in 175 cases (60%), intermediate in 39 (13%) and high grade in 78 (27%). Median follow-up was 26 months. The 5-year OS and DFS rates were respectively 83% and 69%. In multivariate analysis, age (p = 0.004), diabetes (p = 0.02) and advanced stage (p = 0.03) were found to have a significant negative impact on OS. Diabetes (p = 0.001), alcohol consumption (p = 0.003) and advanced stage (p = 0.001) were found to have a significant negative impact on DFS. Compare to low grade, high grade tended to have a negative impact on OS (p = 0.05) and had a significant effect on DFS (0.002) while intermediate grade had no significant influence on survival. The surgical treatment had a positive impact on both OS (p = 0.00005) and DFS (p = 0.0005). Postoperative radiotherapy had no impact in multivariate analysis.Conclusion: Advanced clinical stage, high grade tumor, high age, the impossibility of carrying out a complete surgical resection, and diabetes are the main prognostic factors in this prospective series of patients with MEC. Such findings open new research perspectives on the influence of these components on initial patient care.
- Published
- 2020
- Full Text
- View/download PDF
13. Telemedicine in Audiology. Best practice recommendations from the French Society of Audiology (SFA) and the French Society of Otorhinolaryngology-Head and Neck Surgery (SFORL)
- Author
-
Stéphane Roman, T. Mom, H. Thai-Van, Isabelle Mosnier, Natalie Loundon, Frédéric Venail, C. Villerabel, Didier Bouccara, David Bakhos, M. Marx, Christophe Vincent, Hospices Civils de Lyon (HCL), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon, Institut de l'Audition [Paris] (IDA), Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Imagerie et cerveau (iBrain - Inserm U1253 - UNIV Tours ), Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Société Française de Réflexion Sensori-Cognitive (Sofresc), Service Oto-Rhino-Laryngologie-Chirurgie Cervico-faciale [CHU Necker], CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service d'ORL et de Chirurgie Cervicofaciale, Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Hôpital Pierre-Paul Riquet [Toulouse], CHU Toulouse [Toulouse], Centre de recherche cerveau et cognition (CERCO), Institut des sciences du cerveau de Toulouse. (ISCT), Université Toulouse - Jean Jaurès (UT2J)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Toulouse - Jean Jaurès (UT2J)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre National de la Recherche Scientifique (CNRS), CHU Gabriel Montpied [Clermont-Ferrand], CHU Clermont-Ferrand, Neuro-Dol (Neuro-Dol), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne (UCA), Service d'Oto-Rhino-Laryngologie [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], ORL et Chirurgie cervico-faciale pédiatrique - [Hôpitaux Timone et Nord - APHM], Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE)- Hôpital Nord [CHU - APHM], Institut de Neurosciences des Systèmes (INS), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service d'ORL, Hôpital Gui de Chauliac (CHRU de Montpellier), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut des Neurosciences de Montpellier - Déficits sensoriels et moteurs (INM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Hôpital Roger Salengro [Lille], Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Université Toulouse - Jean Jaurès (UT2J), Université de Toulouse (UT)-Université de Toulouse (UT)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Toulouse - Jean Jaurès (UT2J), Université de Toulouse (UT)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre National de la Recherche Scientifique (CNRS), Service ORL [Hôpital Gui de Chauliac] (CHRU de Montpellier), Hôpital Gui de Chauliac [CHU Montpellier], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut des Neurosciences de Montpellier (INM), Centre Hospitalier Régional Universitaire de Tours (CHRU TOURS), Université de Tours-Institut National de la Santé et de la Recherche Médicale (INSERM), and Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU)
- Subjects
Acoumetry ,Telemedicine ,medicine.medical_specialty ,Medical procedure ,Best practice ,Otoacoustic Emissions, Spontaneous ,Video Recording ,Otoscopy ,Tele-otoscopy ,Otoacoustic emissions ,Virtual reality ,Audiophonology ,03 medical and health sciences ,0302 clinical medicine ,Audiometry ,COVID-19: Preliminary recommendations from the SFORL ,Evoked Potentials, Auditory, Brain Stem ,medicine ,Complaint ,Humans ,Cochlear implant ,Pure-tone audiometry ,[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organs ,030223 otorhinolaryngology ,Hearing Disorders ,Tele-audiometry ,business.industry ,Hearing Tests ,Decision Trees ,COVID-19 ,Audiology ,Presbycusis ,Speech audiometry ,medicine.disease ,3. Good health ,Otorhinolaryngology ,Asynchronous communication ,030220 oncology & carcinogenesis ,Surgery ,The Internet ,France ,Smartphone ,Medical emergency ,business ,Auditory evoked potentials ,Hearing functions - Abstract
International audience; Objectives: Access to diagnosis and treatments for auditory disorders and related pathologies has regressed in France during the COVID-19 pandemic, posing a risk to the patient's chance of recovery. This best practice recommendations guide aims to list the existing technological solutions for the remote examination of a patient with hearing complaint, and to outline their benefits and, where applicable, their limitations.Methods: The recommendations were developed both from the clinical experience of the medical experts who drafted the guide, and from an extensive review of the literature dealing with clinical practice recommendations for tele-audiology. Tele-audiometry solutions were identified on the basis of a search engine query carried out in April 2020, prior to verification of their availability on the European market.Results: Video otoscopy solutions allow for the teletransmission of images compatible with a high-quality diagnosis, either by connecting via internet to a tele-health platform or using a smartphone or a tablet with an iOS or Android operating system. Using the same telecommunication methods, it is possible to remotely conduct a pure-tone audiometry test in accordance with standard practice, a speech-in-quiet or a speech-in-noise audiometry test, as well as objective measures of hearing. Clinical and paraclinical examinations can be accessed by the physician to be interpreted on a deferred basis (asynchronous tele-audiology). Examinations can also be conducted in real time in a patient, at any age of life, as long as a caregiver can be present during the installation of the transducers or the acoumetry. Tele-audiology solutions also find application in the remote training of future healthcare professionals involved in the management of deafness and hearing impairment.Conclusion: Under French law, tele-otoscopy is a medical procedure that is either a tele-expertise (asynchronous adive) or a teleconsultation act (synchronous advice). Subjective and objective evaluation of the patient's hearing functions can be done remotely provided that the listed precautions are respected.
- Published
- 2020
- Full Text
- View/download PDF
14. The French Cochlear Implant Registry (EPIIC): General indicators
- Author
-
A. Bozorg-Grayeli, Valérie Franco-Vidal, T. Mom, S. Moreau, C. Vincent, M. Risoud, Alexandre Karkas, N. Klopp, Stéphane Roman, E. Radafy, Sébastien Schmerber, Olivier Deguine, K. Aubry, Y. Lerosey, S. Roux-Vaillard, C. Parietti, L. Tavernier, C. Eyermann, Eric Truy, Benoit Godey, Nicolas Guevara, J.-P. Lebreton, K. Mezouaghi, F. Merklen, R. Marianowski, M. Labrousse, Philippe Bordure, F. Gauvrit, N. Noël-Petroff, Emmanuel Lescanne, P. Piller, Natalie Loundon, Isabelle Mosnier, C. Poncet, Equipe IFTIM [ImViA - EA7535], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon)-Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER-UNICANCER-Imagerie et Vision Artificielle [Dijon] (ImViA), Université de Bourgogne (UB)-Université de Bourgogne (UB), Institut de Neurosciences des Systèmes (INS), and Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
Quality Control ,Time Factors ,medicine.medical_treatment ,[SDV]Life Sciences [q-bio] ,Advisory Committees ,Health Care Sector ,Guidelines as Topic ,Commission ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,Cochlear implant ,medicine ,Device Approval ,Auditory Brain Stem Implants ,Humans ,030212 general & internal medicine ,Registries ,National commission ,ComputingMilieux_MISCELLANEOUS ,Computer Security ,Device Removal ,Aged ,Aged, 80 and over ,business.industry ,Age Factors ,Infant, Newborn ,Health technology ,Infant ,Reference Standards ,medicine.disease ,Cochlear Implantation ,3. Good health ,Cochlear Implants ,Otorhinolaryngology ,Databases as Topic ,Insurance, Health, Reimbursement ,Surgery ,Medical emergency ,France ,business - Abstract
Cochlear and brainstem implants have been included on the list of reimbursable products (LPPR) in France since March of 2009. The implants were initially inscribed for 5 years, after which an application for renewal with the French National Commission for the Evaluation of Medical Devices and Health Technologies (Commission Nationale d’evaluation des dispositifs medicaux et des technologies de sante – CNEDiMTS) was required [Haute Autorite de sante, 2009]. Upon registration to the list of reimbursable products, the companies and the reference centers for cochlear and brainstem implants were asked to set up a post-registration registry called EPIIC. This article reports the evolution in the EPIIC registry of the general indicators for 5051 patients over the five years from 2012–2016.
- Published
- 2020
- Full Text
- View/download PDF
15. The French National Cochlear Implant Registry (EPIIC): Bilateral cochlear implantation
- Author
-
C. Eyermann, Nicolas Guevara, M. Labrousse, N. Noël-Petroff, K. Mezouaghi, R. Marianowski, Eric Truy, K. Aubry, S. Roux-Vaillard, L. Tavernier, Stéphane Roman, J.-P. Lebreton, N. Klopp, C. Vincent, Alexandre Karkas, Philippe Bordure, F. Merklen, Olivier Deguine, Valérie Franco-Vidal, A. Bozorg-Grayeli, T. Mom, C. Poncet, Cécile Parietti-Winkler, Isabelle Mosnier, C. Lambert, Y. Lerosey, Sébastien Schmerber, M. Puechmaille, S. Moreau, E. Radafy, Benoit Godey, Emmanuel Lescanne, P. Piller, Natalie Loundon, Equipe IFTIM [ImViA - EA7535], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon)-Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER-UNICANCER-Imagerie et Vision Artificielle [Dijon] (ImViA), Université de Bourgogne (UB)-Université de Bourgogne (UB), Institut de Neurosciences des Systèmes (INS), and Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
Adult ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,[SDV]Life Sciences [q-bio] ,Audiology ,Deafness ,03 medical and health sciences ,0302 clinical medicine ,Postoperative Complications ,Cochlear implant ,otorhinolaryngologic diseases ,medicine ,Humans ,Registries ,030223 otorhinolaryngology ,Cochlear implantation ,Child ,ComputingMilieux_MISCELLANEOUS ,Retrospective Studies ,business.industry ,Retrospective cohort study ,Cochlear Implantation ,Cochlear Implants ,Otorhinolaryngology ,030220 oncology & carcinogenesis ,Auditory Perception ,Speech Discrimination Tests ,Speech audiometry ,Surgery ,Female ,Implant ,National registry ,France ,business ,Audiometry, Speech - Abstract
Assessment of the incidence and results of bilateral cochlear implantation in adults and children in France.Multicenter retrospective study of data in the French national registry of cochlear implantations from January 1st 2012 to December 31st 2016. Functional results from CAP (Category of Auditory Performance) questionnaires and speech audiometry tests, with mono- and di-syllabic word-lists, were compared before and after implantation. Speech audiometry tests were carried out against a noisy background, except before simultaneous implantations.Nine hundred and forty two bilateral cochlear implantations were performed during this period, that is, 16.4% of all cochlear implantations. Five hundred and eighty eight bilateral implantations were performed sequentially. 59% of the bilateral implantations were performed in children. Bilateral implants significantly improved CAP scores in all cases (P0.001). Auditory performance, with the two types of word-list, were significantly improved after simultaneous implantation (P0.01). After sequential implantation, the speech discrimination score, already very good with the first implant, reached 63±26% [0-100] with monosyllabic word lists, and 72±28% [0-100] with dissyllabic words. There were more complications due to surgery in bilateral cases than in the entire population of cochlear recipients (9.1% vs 6.4%, P0.02).Hearing is significantly improved by simultaneous cochlear implantation. For sequential implantation, at one year, when auditory results were already excellent from the first implant, in the bimodal condition CAP scores were significantly improved, although there was no further change in speech audiometry in noise.
- Published
- 2020
- Full Text
- View/download PDF
16. The French National Cochlear Implant Registry (EPIIC): Results, quality of life, questionnaires, academic and professional life
- Author
-
Sébastien Schmerber, Cécile Parietti-Winkler, Nicolas Guevara, C. Poncet, Benoit Godey, P. Piller, Stéphane Roman, C. Vincent, N. Klopp, Alexandre Karkas, Eric Truy, Alain Uziel, N. Noël-Petroff, S. Roux-Vaillard, Isabelle Mosnier, Olivier Deguine, A. Bozorg-Grayeli, M. Labrousse, Michel Mondain, L. Tavernier, J.-P. Lebreton, C. Eyermann, K. Mezouaghi, Philippe Bordure, Emmanuel Lescanne, T. Mom, Natalie Loundon, S. Moreau, F. Merklen, Y. Lerosey, E. Radafy, R. Marianowski, Valérie Franco-Vidal, K. Aubry, F. Artieres-Sterkers, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut des Neurosciences de Montpellier - Déficits sensoriels et moteurs (INM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Equipe IFTIM [ImViA - EA7535], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon)-Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER-UNICANCER-Imagerie et Vision Artificielle [Dijon] (ImViA), Université de Bourgogne (UB)-Université de Bourgogne (UB), Université de Lille, Inserm, CHU Lille, Médicaments et biomatériaux à libération contrôlée: mécanismes et optimisation - Advanced Drug Delivery Systems - U 1008 [MBLC - ADDS], Institut des Neurosciences de Montpellier (INM), Institut de Neurosciences des Systèmes (INS), and Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
Hearing aid ,Adult ,Employment ,medicine.medical_specialty ,Self-Assessment ,Time Factors ,Adolescent ,medicine.medical_treatment ,[SDV]Life Sciences [q-bio] ,Audiology ,Deafness ,Professional activity ,Education ,03 medical and health sciences ,0302 clinical medicine ,Quality of life ,Cochlear implant ,Professional life ,Surveys and Questionnaires ,otorhinolaryngologic diseases ,medicine ,Humans ,Registries ,030223 otorhinolaryngology ,Cochlear implantation ,Child ,Registry ,Academic ,Questionnaires ,ComputingMilieux_MISCELLANEOUS ,business.industry ,Speech Intelligibility ,Age Factors ,Infant, Newborn ,Infant ,Cochlear Implantation ,Cochlear Implants ,Treatment Outcome ,Otorhinolaryngology ,Multicenter study ,030220 oncology & carcinogenesis ,Child, Preschool ,Auditory Perception ,Quality of Life ,Ceiling effect ,Surgery ,France ,business ,Follow-Up Studies - Abstract
This study concerns the results of cochlear implantation in children and adults from French cochlear implantation centers, monitored at one, two and three years by the Cochlear Implant French Registry EPIIC. This multicenter study enrolled 2603 subjects (1667 adults and 936 children) implanted in one ear. The following parameters were studied: hearing overall performances, monosyllabic or dissyllabic word perception, speech intelligibility, self-assessment questionnaire of Cochlear Implant (CI) benefits (Abbreviated profile of Hearing aid Benefit); professional activity and schooling. This study confirms the ceiling effect in adults’ performances after the 1st year and the progressive growth in children's performances. It also shows that the contralateral hearing aid enhances performances compared to the CI alone condition, in all follow-up sessions. The French register of CIs is the only worldwide register of systematic follow-up on a period of three years and more of all adults and children implanted in a country. 137;Supplement 1
- Published
- 2020
- Full Text
- View/download PDF
17. The French National Cochlear Implant Registry (EPIIC): Cochlear implantation in adults over 65 years old
- Author
-
Natalie Loundon, T. Mom, Emmanuel Lescanne, N. Noël-Petroff, Isabelle Mosnier, Y. Lerosey, M. Labrousse, Evelyne Ferrary, Sébastien Schmerber, Stéphane Roman, C. Poncet, P. Piller, K. Aubry, S. Moreau, E. Radafy, A. Bozorg-Grayeli, Nicolas Guevara, Eric Truy, K. Mezouaghi, Olivier Sterkers, J.-P. Lebreton, Benoit Godey, Valérie Franco-Vidal, C. Vincent, Alexandre Karkas, N. Klopp, Olivier Deguine, Cécile Parietti-Winkler, C. Eyermann, R. Marianowski, S. Roux-Vaillard, L. Tavernier, F. Merklen, Philippe Bordure, Equipe IFTIM [ImViA - EA7535], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon)-Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER-UNICANCER-Imagerie et Vision Artificielle [Dijon] (ImViA), Université de Bourgogne (UB)-Université de Bourgogne (UB), Institut de Neurosciences des Systèmes (INS), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Lille, Inserm, CHU Lille, and Advanced Drug Delivery Systems (ADDS) - U1008
- Subjects
Hearing aid ,Adult ,Male ,medicine.medical_specialty ,Time Factors ,medicine.medical_treatment ,[SDV]Life Sciences [q-bio] ,Population ,Intelligibility (communication) ,Audiology ,03 medical and health sciences ,Young Adult ,Elderly subject ,Cochlear implant ,Aphab ,CAP ,Intelligibility ,0302 clinical medicine ,Age groups ,otorhinolaryngologic diseases ,medicine ,Humans ,Registries ,030223 otorhinolaryngology ,Cochlear implantation ,education ,Hearing Loss ,ComputingMilieux_MISCELLANEOUS ,Aged ,Retrospective Studies ,Aged, 80 and over ,education.field_of_study ,business.industry ,Communication ,Hearing Tests ,Age Factors ,Patient data ,Middle Aged ,Cochlear Implantation ,Health Surveys ,Cochlear Implants ,Otorhinolaryngology ,030220 oncology & carcinogenesis ,Auditory Perception ,Surgery ,Female ,National registry ,France ,business ,Noise - Abstract
Objectives :To analyze the performance of cochlear implants in French patients aged 65 and over, implanted between 2012 and 2016, using data from the French national registry for cochlear implants (EPIIC). Materials and methods : The French national registry incorporates patient data from before implantation and for three years after implantation, stratified in different age groups (18–39, 40–64 years, 65–74 years and > 75 years). Here, we assessed the latter two categories. Hearing was assessed using mono- and disyllabic words in a silent background. The Category of Auditory Performance (CAP) scale was also implemented and subjects took the Abbreviated Profile of Hearing Aid Benefit (Aphab) questionnaire. Results : The population aged over 65 accounted for 38% (n = 1193) of the 3178 adult implanted patients. The performance for mono- and disyllabic words in silence, the CAP scores and the APHAB questionnaire answers for ease of communication, background noise and reverberation were dramatically improved at one year post-implantation (P < 0.0001 for each score) and remained stable between one and three years thereafter. The percentage improvement was similar across all age groups. The scores for loud-noise intolerance did not change after cochlear implantation in any age group. Conclusion : Cochlear implants improve hearing and communication in subjects aged 65 and over, with comparable efficiency to that achieved in younger subjects. Cochlear implantation should thus be proposed whenever hearing aids provide only limited benefit. However, between 2012 and 2016, cochlear implantation was given to less than 1% of the French population aged 65 and over with profound deafness.
- Published
- 2020
- Full Text
- View/download PDF
18. The French National Cochlear Implant Registry (EPIIC): Cochlear explantation and reimplantation
- Author
-
Isabelle Mosnier, Stéphane Roman, A. Bozorg-Grayeli, Y. Lerosey, Valérie Franco-Vidal, K. Mezouaghi, R. Marianowski, P. Piller, N. Klopp, C. Vincent, Alexandre Karkas, Natalie Loundon, Nicolas Guevara, T. Mom, Olivier Deguine, K. Aubry, Emmanuel Lescanne, S. Roux-Vaillard, Benoit Godey, L. Tavernier, C. Eyermann, Cécile Parietti-Winkler, R Hermann, F. Merklen, M. Labrousse, Sébastien Schmerber, Eric Truy, S. Moreau, J.-P. Lebreton, N. Noël-Petroff, E. Radafy, A. Coudert, C. Poncet, Philippe Bordure, Equipe IFTIM [ImViA - EA7535], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon)-Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER-UNICANCER-Imagerie et Vision Artificielle [Dijon] (ImViA), Université de Bourgogne (UB)-Université de Bourgogne (UB), Institut de Neurosciences des Systèmes (INS), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Lille, Inserm, CHU Lille, Hôpital Edouard Herriot [CHU - HCL], Service d'Oto-rhino-laryngologie (ORL) et chirurgie cervico-faciale [CHU Limoges], Centre hospitalier universitaire de Nantes [CHU Nantes], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand [CHU Dijon], Centre Hospitalier Universitaire de Toulouse [CHU Toulouse], CHU Strasbourg, CHU Bordeaux [Bordeaux], CHU Pontchaillou [Rennes], Hôpital Pasteur [Nice] [CHU], Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] [CHU ST-E], CHU Amiens-Picardie, Centre Hospitalier Universitaire de Reims [CHU Reims], Centre hospitalier universitaire de Poitiers [CHU Poitiers], CHU Rouen, CHU Trousseau [Tours], CHU Necker - Enfants Malades [AP-HP], Hôpital Morvan - CHRU de Brest [CHU - BREST ], Service ORL [Hôpital Gui de Chauliac] [CHRU de Montpellier], Centre Hospitalier Universitaire de La Réunion [CHU La Réunion], CHU Gabriel Montpied [Clermont-Ferrand], CHU Caen, CHU Pitié-Salpêtrière [AP-HP], Hôpital Robert Debré Paris, Hôpital Le Lamentin Bourg [CHU de la Martinique], CHU Marseille, Centre Hospitalier Universitaire d'Angers [CHU Angers], CHU Grenoble, Centre Hospitalier Régional Universitaire de Besançon [CHRU Besançon], and Médicaments et biomatériaux à libération contrôlée: mécanismes et optimisation - Advanced Drug Delivery Systems - U 1008 [MBLC - ADDS]
- Subjects
Adult ,Reoperation ,medicine.medical_specialty ,Time Factors ,Adolescent ,medicine.medical_treatment ,[SDV]Life Sciences [q-bio] ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Cochlear implant ,medicine ,Humans ,Prospective Studies ,Registries ,Child ,030223 otorhinolaryngology ,Cochlear implantation ,Prospective cohort study ,Device Removal ,ComputingMilieux_MISCELLANEOUS ,Aged ,Aged, 80 and over ,business.industry ,Age Factors ,Infant ,Registry ,Reimplantation ,Explantation ,Middle Aged ,Cochlear Implantation ,Prosthesis Failure ,3. Good health ,Surgery ,Cochlear Implants ,Otorhinolaryngology ,Child, Preschool ,Replantation ,030220 oncology & carcinogenesis ,France ,Implant ,business ,Pediatric population - Abstract
This study aims to determine the frequency and causes of cochlear explants with re-implantation (ERI) after 5 years’ follow up of the patients included in the French national EPIIC (étude post-inscription des implants cochléaires) registry tracking patients with cochlear implantation. This multicenter, descriptive prospective study was conducted on 5051 patients enrolled in the EPIIC database between January 2012 and December 2016. Ninety-five patients (1.9%) received a primary implant and an ERI during the study. Of these, four benefitted from two ERIs. The number of ERIs was significantly higher in the pediatric population than among adults. The explantation and reimplantation were performed simultaneously in 86% of cases. The reasons for explantation were: in 46.4% of cases linked to a malfunction of the implant, and in 39.3% of cases for medical or surgical reasons. The number of electrodes inserted was significantly higher after the ERI than after the first implantation. There was just one post-ERI infection for these 95 explanted and re-implanted patients. As well as explantation with reimplantation rarely being necessary, it generally presents no major surgical difficulty and in most cases it allows a better integration than in the first implantation. 137;Supplement 1
- Published
- 2020
- Full Text
- View/download PDF
19. The French Cochlear Implant Registry (EPIIC): Perception and language results in infants with cochlear implantation under the age of 24 months
- Author
-
Stéphane Roman, Eric Truy, Isabelle Mosnier, Nicolas Guevara, J.-P. Lebreton, Rémi Marianowski, Cécile Parietti-Winkler, François Simon, K. Mezouaghi, Y. Lerosey, K. Aubry, C. Poncet, C. Eyermann, Valérie Franco-Vidal, N. Noël-Petroff, S. Moreau, M. Labrousse, C. Vincent, Alexandre Karkas, A. De Lamaze, P. Piller, E. Radafy, T. Mom, S. Roux-Vaillard, N. Klopp, L. Tavernier, F. Merklen, Olivier Deguine, Emmanuel Lescanne, Benoit Godey, Philippe Bordure, Sébastien Schmerber, A. Bozorg-Grayeli, Natalie Loundon, Equipe IFTIM [ImViA - EA7535], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon)-Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER-UNICANCER-Imagerie et Vision Artificielle [Dijon] (ImViA), Université de Bourgogne (UB)-Université de Bourgogne (UB), Institut de Neurosciences des Systèmes (INS), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Lille, Inserm, CHU Lille, and Advanced Drug Delivery Systems (ADDS) - U1008
- Subjects
Reoperation ,medicine.medical_specialty ,Pediatrics ,Time Factors ,medicine.medical_treatment ,[SDV]Life Sciences [q-bio] ,Deafness ,Speech Therapy ,03 medical and health sciences ,0302 clinical medicine ,Mainstreaming, Education ,Cochlear implant ,Epidemiology ,medicine ,Humans ,Correction of Hearing Impairment ,Registries ,030223 otorhinolaryngology ,Cochlear implantation ,Device failure ,ComputingMilieux_MISCELLANEOUS ,Device Removal ,Schools ,business.industry ,Communication ,Speech Intelligibility ,Age Factors ,Infant, Newborn ,Infant ,medicine.disease ,Cochlear Implantation ,3. Good health ,Perception ,Oral language ,National registry ,Child ,Cohort ,Cochlear Implants ,Otorhinolaryngology ,030220 oncology & carcinogenesis ,Auditory Perception ,Education of Hearing Disabled ,Surgery ,Implant ,France ,business ,Meningitis ,Child Language ,Follow-Up Studies - Abstract
Objective Multi-centre study of the National French Registry (EPIIC) of patients with cochlear implants, focusing on infants who were operated-on under the age of 24 months between 2012 and 2016. Patients and methods A total of 615 profoundly deaf infants, who received cochlear implants (CIs) before their second birthday, were included in the registry by different CI centers. Epidemiological, surgical, speech therapy and school, follow-up data were included in the registry, 12, 24, 36 and 48 months thereafter. The following parameters were studied: type of implantation (uni- or bilateral), complications, cause of deafness, category of auditory perception (CAP), Open-set word recognition score (OSW), speech intelligibility rating, lexical comprehension with EVIP (Peabody), communication mode and type of schooling. Bilateral simultaneous CI (BiCI) and unilateral CI (UniCI) groups were compared. Results There were 744 implantations. The explantation-reimplantation rate, within the four-year follow-up, was just 3.6%. Mean implantation age was 16.0 months, and similar in the two groups (BiCI/UniCI). A total of 51% of children had their first implant between 12 and 18 months, and 15% before 12 months. Implantation was unilateral in 52% of cases. Fifty-six percent of the bilateral procedures were sequential, with a mean delay of 16.8 months for the second implantation. The cause of deafness was unknown in 52% of cases. Of the 48% (297/615) of attributed cases, 32% had clear genetic causes. The remaining deafness was due to cytomegalovirus (CMV, 8%), inner-ear malformation (5%) and meningitis (3%). The main complications were from infections (47%) and internal device failure (25%). Four years post-operation, 84% of the UniCI and 75% of BiCl groups had a CAP ≥ 5, and 83% of UniCl and 100% BiCI had OSW ≥ 80%. Furthermore 74% of UniCI and 77% of BiCI communicated orally and 85% of UniCI and 90% of BiCI integrated into mainstream schooling. Conclusion The French Registry of cochlear implants (EPIIC) is the only such national registry in the world. Our analysis illustrates the immediate benefits of, either single or double, cochlear implantation for language, perception skills and schooling.
- Published
- 2020
- Full Text
- View/download PDF
20. The French Cochlear Implant Registry (EPIIC): Cochlear implant candidacy assessment of off-label indications
- Author
-
K. Mezouaghi, Nicolas Guevara, C. Eyermann, Sébastien Schmerber, T. Mom, S. Roux-Vaillard, N. Noël-Petroff, Y. Lerosey, L. Tavernier, Valérie Franco-Vidal, C. Vincent, F. Merklen, Alexandre Karkas, K. Aubry, S. Moreau, C. Poncet, R. Quatre, Cécile Parietti-Winkler, R. Marianowski, M. Labrousse, Eric Truy, Isabelle Mosnier, A. Bozorg-Grayeli, P. Piller, J.-P. Lebreton, Philippe Bordure, E. Radafy, C. Fabre, Natalie Loundon, N. Klopp, Emmanuel Lescanne, Olivier Deguine, Stéphane Roman, Benoit Godey, Equipe IFTIM [ImViA - EA7535], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon)-Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER-UNICANCER-Imagerie et Vision Artificielle [Dijon] (ImViA), Université de Bourgogne (UB)-Université de Bourgogne (UB), Institut de Neurosciences des Systèmes (INS), and Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
Hearing aid ,Male ,Pediatrics ,medicine.medical_treatment ,[SDV]Life Sciences [q-bio] ,Off-label use ,0302 clinical medicine ,Postoperative Complications ,Quality of life ,Cochlear implant ,Postoperative Period ,Prospective Studies ,Registries ,030223 otorhinolaryngology ,Prospective cohort study ,Child ,ComputingMilieux_MISCELLANEOUS ,Aged, 80 and over ,Age Factors ,Middle Aged ,Cochlear Implantation ,030220 oncology & carcinogenesis ,Child, Preschool ,Cohort ,Candidacy ,Female ,France ,Adult ,medicine.medical_specialty ,Adolescent ,[PHYS.PHYS.PHYS-BIO-PH]Physics [physics]/Physics [physics]/Biological Physics [physics.bio-ph] ,Auditory Brain Stem Implantation ,03 medical and health sciences ,Young Adult ,Preoperative Care ,medicine ,Humans ,Hearing Loss ,Aged ,business.industry ,Patient Selection ,Off-Label Use ,Health Surveys ,Cochlear Implants ,Otorhinolaryngology ,Quality of Life ,Speech audiometry ,Surgery ,business ,Audiometry, Speech - Abstract
Evaluate in France the outcomes of cochlear implantation outside the selection criteria, off-label.This is a prospective cohort study including adults and children having received a cochlear implant (CI) in an off-label indication, that is outside the criteria established by the "Haute Autorité de santé (HAS)" in 2012. The data was collected from the "EPIIC" registry on recipients who received CIs in France between 2011 and 2014. Speech audiometry was performed at 60dB preimplantation and after one year of CI use, as well as an evaluation of the scores of the quality of life with the APHAB questionnaire, the scores for CAP and the professional/academic status in pre- and post-implantation conditions. Major and minor complications at surgery have been recorded.In total, 590 patients (447 adults and 143 children) with an off-label indication for CIs were included in this study from the EPIIC registry (11.7% of the whole cohort of EPIIC). For adults, the median percentage of comprehension using monosyllabic word lists was 41% in preimplantation condition versus 53% after one year of CI use (P0.001) and 60% versus 71% in dissyllabic word lists (P0.001). The CAP scores were 5 versus 6 in pre- and post-implantation conditions respectively (P0.001) and the APHAB scores were statistically lower after implantation (P0.001). In the children cohort, the median percentage of comprehension using monosyllabic word lists was 51% in preimplantation condition and 65% after CI (P0.001), and 48% versus 82% (P0.001) for dissyllabic word lists. The CAP scores were 5 versus 7 respectively in pre- and post-CI conditions (P0.001). Thirty-two minor complications (5.4%) and 17 major complications (2.8%) were reported in our panel of off-label indication patients.These results suggest that a revision of the cochlear implantation candidacy criteria is necessary to allow more patients with severe or asymmetric hearing loss to benefit from a CI when there is an impact on quality of life despite the use of an optimal hearing aid.
- Published
- 2020
- Full Text
- View/download PDF
21. Nonconventional Clinical Applications of Otoacoustic Emissions: From Middle Ear Transfer to Cochlear Homeostasis to Access to Cerebrospinal Fluid Pressure
- Author
-
Blandine Lourenço, T. Mom, Fabrice Giraudet, and Paul Avan
- Subjects
medicine.medical_specialty ,medicine.anatomical_structure ,business.industry ,medicine ,Middle ear ,Cerebrospinal fluid pressure ,Audiology ,business ,Homeostasis - Published
- 2020
- Full Text
- View/download PDF
22. Lesioni centrali dell’udito
- Author
-
T. Mom, M. Puechmaille, Paul Avan, and Laurent Gilain
- Subjects
0301 basic medicine ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,media_common.quotation_subject ,Art ,Humanities ,030217 neurology & neurosurgery ,media_common - Abstract
I danni centrali dell’udito comprendono, da una parte, le sordita corticali dovute a lesioni cortico-sotto-corticali, che danno dei quadri semeiologici conosciuti da tempo (sordita verbale, sordita corticale e agnosia uditiva), e, dall’altra, dei disturbi dell’udito meno marcati e di identificazione piu recente, come, per esempio, alcuni ritardi di apprendimento nei bambini e alcune sordita dell’adulto in contrasto con soglie uditive periferiche entro i limiti della norma (obscure auditive dysfonction, sordita latente) e alcune presbiacusie con coinvolgimento centrale. Un danno genetico centrale dell’udito, molto frequente, e rappresentato dall’amusia congenita. Queste lesioni sono difficili da diagnosticare e richiedono, per essere rilevate, degli specifici test soggettivi ed elettrofisiologici. La diagnosi di questi danni centrali dell’udito e, tuttavia, importante da effettuare per migliorare la gestione delle persone colpite, in particolare nel bambino nel pieno periodo dell’apprendimento. Le cause sono molteplici e, tra queste, si annoverano i danni ischemici, emorragici, tumorali, infettivi, degenerativi e iatrogeni (soprattutto chirurgici e radiochirurgici). Alcune cause nei bambini non sono “statiche”, ma in relazione con un’asincronia della maturazione delle vie uditive. L’esplorazione all’esame obiettivo puo aiutare l’elettrofisiologia. Queste tecniche, che utilizzano i potenziali evocati precoci, semiprecoci e tardivi, l’auditory steady state response (ASSR) e la speech-auditory brainstem response (ABR), forniscono delle informazioni limitate sullo stato delle vie acustiche centrali, ma possono aiutare a classificare le diverse patologie responsabili e, soprattutto, a identificare i siti di lesione. La diagnostica per immagini (risonanza magnetica nucleare funzionale [RMf], magnetoencefalografia, tomografia a emissione di positroni [PET]) e promettente ma di applicazione clinica ancora ristretta.
- Published
- 2018
- Full Text
- View/download PDF
23. Trastornos centrales de la audición
- Author
-
T. Mom, M. Puechmaille, Laurent Gilain, and Paul Avan
- Subjects
General Medicine - Abstract
Los trastornos centrales de la audicion engloban, por una parte, las hipoacusias centrales debidas a las lesiones corticosubcorticales, que producen cuadros semiologicos conocidos desde hace mucho tiempo (sordera verbal, sordera cortical y agnosia auditiva) y, por otra parte, los trastornos auditivos menos marcados y que se han identificado mas recientemente, como algunos retrasos del aprendizaje infantiles, algunas hipoacusias del adulto que contrastan con unos umbrales auditivos perifericos dentro de los limites de la normalidad (disfuncion auditiva indefinida [obscure auditive dysfunction]) y algunas presbiacusias con un componente central. Existe tambien una alteracion genetica central de la audicion, que es muy frecuente, denominada amusia congenita. Estas alteraciones son dificiles de diagnosticar y requieren pruebas subjetivas y electrofisiologicas especificas para ser detectadas. Sin embargo, es esencial realizar el diagnostico de estas alteraciones centrales de la audicion para mejorar el tratamiento de las personas afectadas, en especial en los ninos que estan en pleno periodo de aprendizaje. Las etiologias son muy numerosas y engloban las alteraciones geneticas, isquemicas, hemorragicas, tumorales, infecciosas, iatrogenicas (sobre todo quirurgicas y radioquirurgicas) y degenerativas. Algunas causas en la edad pediatrica no son «estaticas», sino que se relacionan con una desincronizacion de la maduracion de las vias auditivas. Las pruebas de imagen funcionales (resonancia magnetica funcional, magnetoencefalografia, tomografia por emision de positrones) son prometedoras, pero su aplicacion clinica aun muy limitada.
- Published
- 2018
- Full Text
- View/download PDF
24. Very painful acute frontal sinusitis revealing granulomatosis with polyangiitis
- Author
-
T. Mom, P. Smets, M. Montero, Laurent Gilain, Service d'ORL et chirurgie cervico-faciale, and CHU Strasbourg-Hôpital de Hautepierre [Strasbourg]
- Subjects
Adult ,Male ,medicine.medical_specialty ,Myeloblastin ,[SDV]Life Sciences [q-bio] ,Pain ,Antibodies, Antineutrophil Cytoplasmic ,Diagnosis, Differential ,03 medical and health sciences ,Frontal Sinusitis ,0302 clinical medicine ,Recurrence ,Necrotizing Vasculitis ,Biopsy ,medicine ,Humans ,030223 otorhinolaryngology ,Sinusitis ,Survival rate ,medicine.diagnostic_test ,business.industry ,Granulomatosis with Polyangiitis ,Chronic sinusitis ,medicine.disease ,3. Good health ,Otorhinolaryngology ,030220 oncology & carcinogenesis ,Surgery ,Rituximab ,Radiology ,Tomography, X-Ray Computed ,Granulomatosis with polyangiitis ,business ,medicine.drug - Abstract
Introduction Granulomatosis with polyangiitis (GPA) is a necrotizing vasculitis of small and medium-sized vessels comprising inflammation of the vessel wall and perivascular and extravascular granulomas, frequently presenting in the form of chronic sinusitis. Observation We report the case of a 27-year-old man who presented with very painful acute frontal sinusitis that was managed medically and surgically. The symptoms rapidly recurred despite treatment and CT scan demonstrated diffuse thickening of the sinus mucosa. Anti-proteinase 3 ANCA were positive. Biopsy of a pulmonary nodule confirmed the diagnosis of GPA. The patient was treated with corticosteroids in combination with rituximab, resulting in improvement of the clinical, laboratory and CT signs. Discussion In the presence of persistent, acute, localized sinusitis despite appropriate treatment, associated systemic signs and/or the presence of other signs suggestive of GPA, the ENT surgeon must request a targeted work-up. In the absence of treatment, GPA can be fatal within a few months. However, with currently available treatment, remission is obtained in 80% of cases with a 75% 10-year survival rate.
- Published
- 2019
- Full Text
- View/download PDF
25. Adénome parathyroïdien ectopique du sinus piriforme : spécificités diagnostiques et chirurgicales
- Author
-
M. Simonson, Sarah Dallel, S. Roumeau, Thomas Benichou, Igor Tauveron, and T. Mom
- Subjects
Endocrinology ,Endocrinology, Diabetes and Metabolism ,General Medicine - Abstract
Introduction Les adenomes parathyroidiens ectopiques dans le sinus piriforme sont exceptionnels. Cette localisation peut modifier la demarche diagnostique et chirurgicale. Observation Le diagnostic d’hyperparathyroidie primaire est porte chez une patiente de 59 ans asthenique. La scintigraphie 99mTc-MIBI/123I SPECT-CT retrouve une heterogeneite de fixation non specifique a droite du laryngopharynx sans anomalie scanographique en regard, pas d’image d’adenome parathyroidien. A 61 ans, devant une osteoporose fracturaire, une reevaluation endocrinologique montre : calcemie corrigee/albuminemie 2,83 mmol/L, phosphore 0,80 mmol/L, PTH a 119 pg/mL (N 12–88), creatininemie 65 μmol/l, vitamine D 24 ng/mL, calciurie 18,7 mmol/24 h. L’echographie cervicale ne localise pas d’adenome. Un TEP 18F-Choline decrit une structure hyperfixante de 8 mm du sinus piriforme droit compatible avec un adenome parathyroidien ectopique P3 droit. Un scanner 4 T confirme une lesion nodulaire de 9 mm du sinus piriforme droit spontanement hypodense, hyperarterialisee avec un discret washout (densite spontanee Conclusion Un bilan morphologique de premiere intention negatif pour hyperparathyroidie primaire doit faire rechercher un adenome ectopique dans le sinus piriforme par TEP 18F-Choline et nasofibroscopie. Il peut etre gueri par une chirurgie endoscopique.
- Published
- 2021
- Full Text
- View/download PDF
26. Functional results in endoscopic Zenker's diverticulum surgery
- Author
-
Nicolas Saroul, T. Mom, R. Pastourel, Laurent Gilain, and A Dissard
- Subjects
Adult ,Male ,medicine.medical_specialty ,Zenker Diverticulum ,medicine.medical_treatment ,Recurrence risk ,03 medical and health sciences ,Zenker's diverticulum ,Age Distribution ,0302 clinical medicine ,Recurrence ,Risk Factors ,otorhinolaryngologic diseases ,medicine ,Humans ,Sex Distribution ,Aged ,Retrospective Studies ,Aged, 80 and over ,business.industry ,General surgery ,Retrospective cohort study ,Length of Stay ,Middle Aged ,Marsupialization ,medicine.disease ,Dysphagia ,Surgery ,Treatment Outcome ,Otorhinolaryngology ,030220 oncology & carcinogenesis ,Regurgitation (digestion) ,Female ,030211 gastroenterology & hepatology ,Esophagoscopy ,medicine.symptom ,business ,Oral feeding ,Diverticulum ,Follow-Up Studies - Abstract
Objectives The main objective of this retrospective study was to assess functional results in endoscopic Zenker's diverticulum surgery. The secondary objectives were to assess safety, identify recurrence risk factors, and determine optimal management of recurrence. Material and methods From 2000 to 2014, 50 patients underwent endoscopic surgery for marsupialization of Zenker's diverticulum. Regurgitation and dysphagia were assessed on the FOIS scale, pre- and post-operatively. Recurrences and complications rates were determined retrospectively at a minimum 18 months’ follow-up. Results Regurgitation and dysphagia improved in respectively 96% and 86% of patients. There was a 12% rate of complications, mostly minor. Mean hospital stay and time to return to oral feeding were 2.0 and 1.3 days respectively. Nine patients (18%) showed recurrence of symptoms, requiring revision surgery at a mean 2.7 years, performed endoscopically in the majority of cases. Only one recurrence risk factor was identified: small diverticulum size. Conclusion Endoscopic Zenker's diverticulum surgery provided functional improvement in most cases. Safe and effective, it is currently the treatment of choice for Zenker's diverticulum.
- Published
- 2017
- Full Text
- View/download PDF
27. Sinusite frontale aiguë hyperalgique révélatrice d’une granulomatose avec polyangéite
- Author
-
Laurent Gilain, P. Smets, M. Montero, T. Mom, Service d’ORL et Chirurgie Cervico-Faciale [CHU Clermont-Ferrand], CHU Gabriel Montpied [Clermont-Ferrand], and CHU Clermont-Ferrand-CHU Clermont-Ferrand
- Subjects
030203 arthritis & rheumatology ,03 medical and health sciences ,[SPI]Engineering Sciences [physics] ,0302 clinical medicine ,Otorhinolaryngology ,Surgery ,030223 otorhinolaryngology ,3. Good health - Abstract
Resume Introduction La granulomatose avec polyangeite (GPA) est une vascularite necrosante des vaisseaux de petit et moyen calibre associant une inflammation de la paroi vasculaire et des granulomes, peri- et extra-vasculaires, frequemment revelee par une atteinte sinusienne chronique. Observation Nous rapportons l’observation d’un patient âge de 27 ans qui a presente une sinusite frontale aigue hyperalgique prise en charge par traitement medical et chirurgical. Malgre le traitement, la symptomatologie recidivait precocement et le scanner retrouvait des epaississements muqueux sinusiens diffus. Les ANCA diriges contre la proteinase 3 etaient positifs. Un nodule pulmonaire a ete biopsie confirmant le diagnostic de GPA. Le patient a ete traite par une corticotherapie en association avec du rituximab, ce qui a permis d’obtenir une amelioration clinique, biologique et scannographique. Discussion En cas d’atteinte sinusienne localisee aigue et persistante malgre un traitement adapte, de signes generaux associes et/ou de survenue de signes evocateurs de la GPA, l’ORL doit savoir demander un bilan oriente. En l’absence de traitement, la GPA pet etre mortelle en quelques mois. Grâce au traitement actuel, la remission est obtenue dans 80 % des cas avec un taux de survie de 75 % a 10 ans.
- Published
- 2019
- Full Text
- View/download PDF
28. Impact of nutritional status at the outset of assessment on postoperative complications in head and neck cancer
- Author
-
T. Mom, C. Caburet, Laurent Gilain, N. Farigon, Y. Boirie, Aurélien Mulliez, Nicolas Saroul, Service d’ORL et Chirurgie Cervico-Faciale [CHU Clermont-Ferrand], CHU Gabriel Montpied [Clermont-Ferrand], CHU Clermont-Ferrand-CHU Clermont-Ferrand, Service de Nutrition Clinique [CHU Clermont-Ferrand], Unité de Biostatistiques [CHU Clermont-Ferrand], and Direction de la recherche clinique et de l’innovation [CHU Clermont-Ferrand] (DRCI)
- Subjects
medicine.medical_specialty ,Sarcopenia ,Clavien-Dindo Classification ,[SDV]Life Sciences [q-bio] ,Nutritional Status ,Lumbar vertebrae ,03 medical and health sciences ,0302 clinical medicine ,Postoperative Complications ,Internal medicine ,medicine ,Humans ,030223 otorhinolaryngology ,Retrospective Studies ,2. Zero hunger ,Performance status ,business.industry ,Head and neck cancer ,Retrospective cohort study ,medicine.disease ,Head and neck squamous-cell carcinoma ,3. Good health ,Malnutrition ,medicine.anatomical_structure ,Otorhinolaryngology ,Head and Neck Neoplasms ,030220 oncology & carcinogenesis ,Surgery ,business - Abstract
Half of the patients presenting with head and neck tumor are malnourished at the outset of treatment. Muscle mass loss (sarcopenia) seems to be critical. The aim of the present study was to assess the impact of nutritional status and sarcopenia on postoperative complications in head and neck cancer.A retrospective study for the period November 2014 to May 2016 included 92 patients operated on for head and neck squamous cell carcinoma. Complications at 30 days were graded on the 5-level Clavien-Dindo classification. Nutritional status was assessed anthropometrically (weight), biologically (albuminemia and Nutrition Risk Index (NRI)), on CT (muscle mass index at 3rd lumbar vertebra) and functionally (Short Physical Performance Battery). Assessment was made at the outset of management, and nutritional treatment was initiated as appropriate. Potential risk factors for postoperative complications were assessed: performance status, prior radiation therapy, smoking and alcohol abuse.54% of patients were malnourished on the NRI. 41% had grade≥2 complications. The most frequent complications were infection and healing disorder. The risk of complications was higher in case of malnutrition (62% vs. 17%; P0.001) and sarcopenia (56% vs. 22%; P0.01), with 50% longer hospital stay (P=0.04).Malnutrition and sarcopenia are independent risk factors for postoperative complications.
- Published
- 2019
- Full Text
- View/download PDF
29. Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France
- Author
-
A. Moya-Plana, A. Aupérin, R. Obongo, A. Baglin, F.R. Ferrand, B. Baujat, N. Saroul, O. Casiraghi, S. Vergez, P. Herman, F. Janot, J. Thariat, B. Vérillaud, L. de Gabory, S. Albert, G. Andry, E. Babin, C. Bach, J.-M. Badet, C. Badoual, A.C. Baglin, A. Banal, B. Barry, E. Baudin, R.J. Bensadoun, C. Bertolus, J.-P. Bessède, D. Blanchard, C. Borel, A. Bozorg-Grayeli, R. Breheret, P. Breton, L. Brugel, G. Calais, E. Cassagnau, L. Castillo, P. Ceruse, F. Chabolle, D. Chevalier, J.C. Chobaut, O. Choussy, A. Cosmidis, A. Coste, V. Costes, L. Crampette, V. Darrouzet, P. Demez, P. Dessi, B. Devauchelle, L. Digue, G. Dolivet, F. Dubrulle, S. Duflo, X. Dufour, C. Even, S. Faivre, N. Fakhry, C. Ferron, F. Floret, R. Garrel, L. Geoffrois, L. Gilain, A. Giovanni, A. Girod, B. Guerrier, S. Hans, P. Hofman, M. Housset, R. Jankowski, F. Jegoux, M. Juliéron, M.-C. Kaminsky, F. Kolb, J. Lacau St Guily, L. Laccoureye, B. Lallemant, P. Lang, E. Lartigau, J.-P. Lavieille, M. Lefevre, X. Leroy, O. Malard, F. Massip, O. Mauvais, J.-C. Merol, J. Michel, T. Mom, S. Morinière, E. de Monès, G. Moulin, G. Noel, G. Poissonnet, J.-M. Prades, D. de Raucourt, E. Reyt, C. Righini, Y. Marie Robin, F. Rolland, B. Ruhin, N. Sarroul, P. Schultz, E. Serrano, O. Sterkers, V. Strunski, A. Sudaka, M. Tassart, S. Testelin, A. Timochenko, B. Toussaint, E. Uro Coste, G. Valette, T. Van den Abbeele, A. Varoquaux, F. Veillon, M. Wassef, Institut Gustave Roussy (IGR), Service de biostatistique et d'épidémiologie (SBE), Direction de la recherche clinique [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), Département de cancérologie cervico-faciale [Gustave Roussy] (CCF), Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Clermont-Ferrand, Laboratorium für Physikalische Chemie (ETH-LPC), Eidgenössische Technische Hochschule - Swiss Federal Institute of Technology [Zürich] (ETH Zürich), French Rare Head and Neck Cancer Expert Network (REFCOR), Service d'Oto-Rhino-Laryngologie (O.R.L.) et de Chirurgie Cervico-Faciale [CHU Caen], Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN), French Rare Head and Neck Cancer Expert Network. (REFCOR), Laboratoire d'études spatiales et d'instrumentation en astrophysique (LESIA), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut national des sciences de l'Univers (INSU - CNRS)-Observatoire de Paris, Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), Service d'ORL et de Chirurgie Cervico-Faciale (PARIS - BICHAT - ORL et CCF), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Médecine nucléaire, Département d'imagerie médicale [Gustave Roussy], Service d’ORL et de chirurgie cervico-faciale [CHU Tenon], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre Paul Strauss de Lutte contre le Cancer (Strasbourg), Génétique, immunothérapie, chimie et cancer (GICC), UMR 6239 CNRS [2008-2011] (GICC UMR 6239 CNRS), Université de Tours (UT)-Centre National de la Recherche Scientifique (CNRS), Hôpital de la Croix-Rousse [CHU - HCL], Hospices Civils de Lyon (HCL), Chambre Régionale d'Agriculture des Pays de la Loire, Service de chirurgie, Hôpital Charles Nicolle [Rouen]-CHU Rouen, Normandie Université (NU)-Normandie Université (NU), Service d’Otorhinolaryngologie [Centre Hospitalier Lyon Sud - HCL], Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Université de Montpellier (UM), Service d'ORL, CHU Bordeaux [Bordeaux]-Groupe hospitalier Pellegrin, Anthropologie bio-culturelle, Droit, Ethique et Santé (ADES), Aix Marseille Université (AMU)-EFS ALPES MEDITERRANEE-Centre National de la Recherche Scientifique (CNRS), Département de chirurgie maxillofaciale et stomatologie [CHU d'Amiens-Picardie], CHU Amiens-Picardie, Institut de Cancérologie de Lorraine - Alexis Vautrin [Nancy] (UNICANCER/ICL), UNICANCER, Service de Radiologie (LILLE - Radio), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Service de médecine gériatrique, CHU de Saint-Etienne, Université Paris 13 (UP13), Hôpital Pellegrin, Service d'ORL et chirurgie cervico-faciale, Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Service d'ORL et Chirurgie Cervico-Facial, Hôpital de la Timone [CHU - APHM] (TIMONE), Fluides, automatique, systèmes thermiques (FAST), Université Paris-Sud - Paris 11 (UP11)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Centre National de la Recherche Scientifique (CNRS), Laboratoire Géomatériaux (DGCB-LGM), École Nationale des Travaux Publics de l'État (ENTPE)-Centre National de la Recherche Scientifique (CNRS), Neurobiologie des réseaux sensorimoteurs (NRS (U7060)), Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Centre National de la Recherche Scientifique (CNRS), Centre méditérannéen de médecine moléculaire (C3M), Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service d'Oto-Rhino-Laryngologie et de Chirurgie Cervico-Faciale [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), CHU Pontchaillou [Rennes], Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), University of St Andrews [Scotland], Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] (UNICANCER/Lille), Université Lille Nord de France (COMUE)-UNICANCER, Centre hospitalier universitaire de Nantes (CHU Nantes), Statistique en grande dimension pour la génomique, Département PEGASE [LBBE] (PEGASE), Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Universitaire de Reims (CHU Reims), Institut d'Electronique du Solide et des Systèmes (InESS), Centre National de la Recherche Scientifique (CNRS), Service d'ORL et de Chirurgie Cervico-Faciale (TOURS - ORL et CCF), Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Université de Rennes (UNIV-RENNES), Service de chirurgie oncologique cervico-faciale [centre Antoine Lacassagne, Nice], Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA)-UNICANCER-Université Côte d'Azur (UCA), Department of Otolaryngology and Head and Neck Surgery, University Hospital of Grenoble, BP 217, 38043, Grenoble Cedex 09, France, Université Joseph Fourier - Grenoble 1 (UJF), Institut d'oncologie/développement Albert Bonniot de Grenoble (INSERM U823), Institut National de la Santé et de la Recherche Médicale (INSERM)-EFS-CHU Grenoble-Université Joseph Fourier - Grenoble 1 (UJF), CRLCC René Gauducheau, CHU Strasbourg-Hôpital de Hautepierre [Strasbourg], Réhabilitation Chirurgicale mini-Invasive et Robotisée de l'Audition, Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU), Centre de résonance magnétique biologique et médicale (CRMBM), Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Centre National de la Recherche Scientifique (CNRS), Laboratoire de cristallographie et sciences des matériaux (CRISMAT), École Nationale Supérieure d'Ingénieurs de Caen (ENSICAEN), Normandie Université (NU)-Normandie Université (NU)-Centre National de la Recherche Scientifique (CNRS)-Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Institut de Chimie du CNRS (INC), Department of Head and Neck Surgery, Hôpital Larrey [Toulouse], CHU Toulouse [Toulouse]-CHU Toulouse [Toulouse], Service d'oto-rhino-laryngologie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Lariboisière-Fernand-Widal [APHP], Biomécanique et génie biomédical (BIM), Réseau d’Expertise Français sur les Cancers ORL Rares - French Network of Rare Head and Neck Tumors (REFCOR), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Groupe innovation et ciblage cellulaire (GICC), EA 7501 [2018-...] (GICC EA 7501), Université de Tours (UT), Hôpital Charles Nicolle [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-CHU Rouen, Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E), Université Nice Sophia Antipolis (1965 - 2019) (UNS), Université de Lille-UNICANCER, Université de Rennes (UR), Université Joseph Fourier - Grenoble 1 (UJF)-CHU Grenoble-EFS-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Santé et de la Recherche Médicale (INSERM), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN), Normandie Université (NU)-Normandie Université (NU)-École Nationale Supérieure d'Ingénieurs de Caen (ENSICAEN), Normandie Université (NU)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche sur les Matériaux Avancés (IRMA), Normandie Université (NU)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Institut national des sciences appliquées Rouen Normandie (INSA Rouen Normandie), Institut National des Sciences Appliquées (INSA)-Normandie Université (NU)-Institut National des Sciences Appliquées (INSA)-Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université de Rouen Normandie (UNIROUEN), Institut National des Sciences Appliquées (INSA)-Normandie Université (NU)-Institut National des Sciences Appliquées (INSA)-Centre National de la Recherche Scientifique (CNRS), Les Hôpitaux Universitaires de Strasbourg (HUS), Service Chirurgie maxillo-faciale et plastique de la face [CHU Toulouse], Pôle Céphalique [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Université de Tours-Centre National de la Recherche Scientifique (CNRS), and Assistance Publique - Hôpitaux de Marseille (APHM)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
0301 basic medicine ,Oncology ,Male ,Cancer Research ,Multivariate analysis ,medicine.medical_treatment ,0302 clinical medicine ,Paranasal Sinuses ,Medicine ,Prospective Studies ,Stage (cooking) ,Head and neck ,Lymph node ,Melanoma ,Aged, 80 and over ,Mucosal melanoma ,Middle Aged ,Prognosis ,Progression-Free Survival ,3. Good health ,Tumor Burden ,Survival Rate ,medicine.anatomical_structure ,Head and Neck Neoplasms ,030220 oncology & carcinogenesis ,Female ,Mouth Neoplasms ,France ,Algorithms ,Paranasal Sinus Neoplasms ,Adult ,medicine.medical_specialty ,Nose Neoplasms ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,03 medical and health sciences ,Young Adult ,Internal medicine ,Humans ,Sinonasal ,Aged ,Neoplasm Staging ,Radiotherapy ,business.industry ,Head and neck cancer ,Mouth Mucosa ,medicine.disease ,Otorhinolaryngologic Surgical Procedures ,Oral cavity ,Radiation therapy ,Nasal Mucosa ,030104 developmental biology ,Oral Cavity Mucosal Melanoma ,Radiotherapy, Adjuvant ,business - Abstract
International audience; BACKGROUND:Head and neck mucosal melanoma (HNMM) is aggressive and rare, with a poor prognosis because of its high metastatic potential. The two main subtypes are sinonasal (sinonasal mucosal melanoma [SNMM]) and oral cavity (oral cavity mucosal melanoma [OCMM]). Consensual therapeutic guidelines considering the primary tumour site and tumour-node-metastasis (TNM) stage are not well established.MATERIAL & METHODS:Patients with HNMM from the prospective national French Rare Head and Neck Cancer Expert Network database between 2000 and 2017 were included. Clinical characteristics, treatment modalities, outcomes and prognostic factors were analysed.RESULTS:In total, 314 patients were included. The 5-year overall survival (OS) and progression-free survival (PFS) rates were 49.4% and 24.7%, respectively, in the surgery group; no long-term survivors were observed when surgery was not feasible. Moreover, even after surgery, a high recurrence rate was reported with a median PFS of 22 months. In multivariate analysis, Union for International Cancer Control (UICC) stage and tumour site correlated with PFS and OS. Postoperative radiotherapy (PORT) improved the PFS but not OS in patients with small (T3) SNMM and OCMM tumours. Nodal involvement was more frequent in patients with OCMM (p < 10-4), although, as in SNMM, it was not a significant prognostic predictor.CONCLUSION:Even early HNMM was associated with poor oncologic outcomes due to distant metastases despite surgical resection with clear margins. Lymph node metastases had no impact on the prognosis, suggesting treatment de-escalation in cervical node management. PORT might be useful for local control.
- Published
- 2019
- Full Text
- View/download PDF
30. Application of SARIMA to Modelling and Forecasting Money Circulation in Nigeria
- Author
-
C.C. Eleke, T Mom, C.E. Adubisi, and O. D. Adubisi
- Subjects
Macroeconomics ,Economy ,Economics ,Circulation (currency) ,General Medicine - Published
- 2017
- Full Text
- View/download PDF
31. La dysplasie fibreuse osseuse cranio-faciale
- Author
-
A. Couturier, Marc André, Olivier Aumaître, T. Mom, and L. Gilain
- Subjects
Pathology ,medicine.medical_specialty ,Mastoiditis ,biology ,business.industry ,Fibrous dysplasia ,Gastroenterology ,030209 endocrinology & metabolism ,Congenital skeletal disorder ,medicine.disease ,03 medical and health sciences ,Cushing syndrome ,0302 clinical medicine ,Nasolacrimal duct obstruction ,030220 oncology & carcinogenesis ,Internal Medicine ,medicine ,GNAS complex locus ,biology.protein ,Precocious puberty ,Craniofacial ,business - Abstract
Fibrous dysplasia of bone is a benign, uncommon, sporadic, congenital skeletal disorder resulting in deformity. This disease arises from activating somatic mutation in GNAS which encodes the α subunit of the G stimulatory protein associated with proliferation of undifferentiated osteogenic cells resulting in marrow fibrosis, abnormal matrix production, and stimulation of osteoclastic resorption upon overproduction of IL-6 observed in dysplastic cells. Fibrous dysplasia may be monostotic or polyostotic. This mutation affecting many tissues, cafe au lait skin macules and endocrinopathies (precocious puberty, hyperthyroidism, growth hormone excess, Cushing syndrome) may be associated in McCune-Albright syndrome, but also myxoma in Mazabraud syndrome or phosphate diabetes. Diagnosis of craniofacial fibrous dysplasia should be considered in the presence of headache, neuralgia, sensory disorders (vision, hearing, balance, smelling), functional disorders (nasal obstruction, nasolacrimal duct obstruction, non-matching occlusion), infectious complications (sinusitis, otitis, mastoiditis). Such symptoms should lead to perform craniofacial CT scan completed with MRI. Bone biopsy is not systematic. Surgical treatment is discussed in cases of nervous complication, facial deformity or active lesions. In case of pain resistant to conventional analgesics, intravenous bisphosphonates can be proposed. In non-responder patients, several case reports suggest the efficacy of a monoclonal antibody directed against the IL-6 receptor which requires to be confirmed by randomized studies.
- Published
- 2016
- Full Text
- View/download PDF
32. Prognostic value of two tumour staging classifications in patients with sinonasal mucosal melanoma
- Author
-
Nicolas Saroul, Aurélien Mulliez, Laurent Gilain, T. Mom, and A. Houette
- Subjects
Male ,medicine.medical_specialty ,Nose Neoplasms ,03 medical and health sciences ,0302 clinical medicine ,Paranasal Sinuses ,medicine ,Humans ,Neoplasm Invasiveness ,030223 otorhinolaryngology ,Melanoma ,Survival analysis ,Aged ,Neoplasm Staging ,Retrospective Studies ,Cancer staging ,Aged, 80 and over ,business.industry ,Mucosal melanoma ,Cancer ,Retrospective cohort study ,Middle Aged ,Prognosis ,medicine.disease ,Surgery ,Log-rank test ,Nasal Mucosa ,Paranasal sinuses ,medicine.anatomical_structure ,Otorhinolaryngology ,030220 oncology & carcinogenesis ,Female ,France ,Radiology ,business ,Paranasal Sinus Neoplasms - Abstract
Introduction Sinonasal mucosal melanoma is a rare disease associated with a very poor prognosis. The purpose of this study was to assess the prognostic value of the 2 staging systems published in the literature for these tumours: the American Joint Committee on Cancer (AJCC) Cancer Staging Manual for mucosal melanoma of the head and neck published in 2009 (7th edition) and the AJCC Cancer Staging Manual for cancers of the nasal cavity and paranasal sinuses published in 2002 (6th edition) and the prognostic value of tumour site, either limited to the nasal cavities or with paranasal sinus invasion. Methods A retrospective study was conducted on 18 patients treated between August 1998 and June 2014. Each lesion was staged according to the AJCC Cancer Staging Manual 2002 and 2009 and the following data were collected: age, sex, tumour site, initial symptoms, treatment modalities, follow-up, recurrences and overall survival. Patient survival, from the date of discovery of the melanoma until death, was analysed by Kaplan-Meier survival curves and between-group comparison of survival was performed with a log rank test. Results The mean age at diagnosis was 72 years (range: 54–94) and the cohort comprised 11 women and 7 men. The median overall survival was 80 months, the 1-year overall survival was 82.6% and the 5-year overall survival was 54.5%. The AJCC 2002 staging system presented a statistically significant prognostic value (P = 0.0476), while no statistically significant prognostic value was observed for the AJCC 2009 staging system (P = 0.108). Paranasal sinus invasion was significantly associated with a poor prognosis (P = 0.0039). Conclusion This study demonstrates the superiority of the non-specific AJCC 2002 Cancer Staging Manual. Medical and surgical management must take paranasal sinus invasion into account, as it constitutes a major prognostic factor.
- Published
- 2016
- Full Text
- View/download PDF
33. Rapid exhaustion of auditory neural conduction in a prototypical mitochondrial disease, Friedreich ataxia
- Author
-
Alexandra Durr, Perrine Charles, T. Mom, Odile Boespflug-Tanguy, Paul Avan, Paul Deltenre, Fabrice Giraudet, Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP), UNICANCER, Service de Génétique Cytogénétique et Embryologie [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service ORL, Hôtel-Dieu, Génétique, Reproduction et Développement (GReD), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020])-Centre National de la Recherche Scientifique (CNRS), Institut du Cerveau et de la Moëlle Epinière = Brain and Spine Institute (ICM), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-CHU Pitié-Salpêtrière [AP-HP], Equipe Biophysique Neurosensorielle [Neuro-Dol], Neuro-Dol (Neuro-Dol), Université d'Auvergne - Clermont-Ferrand I (UdA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université d'Auvergne - Clermont-Ferrand I (UdA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Neuro-Dol (Neuro-Dol), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020])-Université Clermont Auvergne [2017-2020] (UCA [2017-2020]), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], and Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Adult ,Male ,0301 basic medicine ,medicine.medical_specialty ,Ataxia ,Adolescent ,Mitochondrial disease ,[SDV]Life Sciences [q-bio] ,Neural Conduction ,Audiology ,Intelligibility (communication) ,Nerve conduction velocity ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Time frame ,Hearing ,Auditory neuropathy spectrum disorder ,Physiology (medical) ,Evoked Potentials, Auditory, Brain Stem ,otorhinolaryngologic diseases ,medicine ,Humans ,In patient ,Child ,ComputingMilieux_MISCELLANEOUS ,business.industry ,Speech Intelligibility ,Auditory Threshold ,Middle Aged ,medicine.disease ,Sensory Systems ,030104 developmental biology ,Neurology ,Friedreich Ataxia ,Auditory Perception ,Speech Perception ,Audiometry, Pure-Tone ,Female ,sense organs ,Neurology (clinical) ,medicine.symptom ,business ,030217 neurology & neurosurgery - Abstract
Objectives In patients with Friedreich ataxia (FRDA), mitochondrial failure leads to impaired cellular energetics. Since many FRDA patients have impaired hearing in noise, we investigated the objective consequences on standard auditory brainstem-evoked responses (ABRs). Methods In 37 FRDA patients, among whom 34 with abnormal standard ABRs, hearing sensitivity, speech-in-noise intelligibility and otoacoustic emissions were controlled. ABR recordings were split into four consecutive segments of the total time frame used for data collection, thus allowing the dynamics of ABR averaging to be observed. Results Most ears showed features of an auditory neuropathy spectrum disorder with flattened ABRs and impaired speech-in-noise intelligibility contrasting with near-normal hearing sensitivity and normal preneural responses. Yet split-ABRs revealed short-lived wave patterns in 26 out of 68 ears with flattened standard ABRs (38%). While averaging went on, the pattern of waves shifted so that interwave latencies increased by 35% on average. Conclusions In FRDA, the assumption of stationarity used for extracting standard ABRs is invalid. The preservation of early split-ABRs indicates no short-term dyssynchrony of action potentials. A large decrease in conduction velocity along auditory neurons occurs within seconds, attributed to fast energetic failure. Significance This model of metabolic sensory neuropathy warns against exposure of metabolically-impaired patients to sustained auditory stimulation.
- Published
- 2018
- Full Text
- View/download PDF
34. Techniques d'explorations innovantes de l'audition
- Author
-
P. Avan, A. Moulin, V. Franco, F. Pavani, E. Veuillet, N. Deggouj, Olivier Deguine, A. Neagu, M. Puechmaille, H. Thai-Van, Fabrice Giraudet, V. Darrouzet, Q. Martinez, D. Bakhos, T. Mom, A. Villeneuve, Valérie Gaveau, C. Lorenzi, A. Alhamwi, P. Barone, A. Farné, and E. Truy
- Published
- 2018
- Full Text
- View/download PDF
35. Baha-Mediated Rehabilitation of Patients with Unilateral Deafness: Selection Criteria
- Author
-
Mohamed Akkari, Laurent Gilain, Nicolas Saroul, T. Mom, and Y. Pavier
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Physiology ,Hearing loss ,medicine.medical_treatment ,Audiology ,Hearing Loss, Unilateral ,Young Adult ,Speech and Hearing ,Hearing Aids ,Patient satisfaction ,Audiometry ,Surveys and Questionnaires ,otorhinolaryngologic diseases ,medicine ,Humans ,Sound Localization ,Young adult ,Child ,Aged ,Retrospective Studies ,Aged, 80 and over ,Rehabilitation ,medicine.diagnostic_test ,business.industry ,Patient Selection ,Retrospective cohort study ,Middle Aged ,medicine.disease ,Sensory Systems ,Treatment Outcome ,Otorhinolaryngology ,Patient Satisfaction ,Speech Perception ,Female ,Implant ,Unilateral hearing loss ,medicine.symptom ,business ,Bone Conduction - Abstract
The aim of our study was to identify clinical criteria for optimizing rehabilitation of patients with unilateral deafness using the Baha device. We made a retrospective study of 102 patients with unilateral deafness requesting auditory rehabilitation over a period of 5 years. All subjects underwent a series of stereo audiometric tests, with and without Baha worn on a headband, and were then referred to a hearing care specialist for a real life trial of 15 days. The Glasgow Health Status Inventory (GHSI) questionnaire was administered. Patients refusing the implantation were retrospectively submitted to a questionnaire specifically designed to ask the reasons for refusal. We measured stereo audiometric test results, age, aetiology of deafness, duration of auditory deprivation on the rehabilitated ear, and GHSI score. At the conclusion of testing, the implantation rate was 29%. During preoperative testing, the improvement in understanding of speech-in-noise was 22 ± 11% for patients agreeing to the implantation versus 13 ± 11% for patients refusing the implantation. Age, aetiology of deafness and duration of auditory deprivation had no influence on the implantation decision. Speech-in-noise testing and aided stereo audiometric gain were the only two measures showing statistically significant differences between the groups agreeing to and refusing the implantation. There were multiple reasons for refusal of the implantation. Among these, the four principal reasons were: absence of perceived benefit during stereo audiometric testing (59%), requirement for surgery (35%), cost of the solution (44%), and aesthetics (41%). Hence, no other criteria except the preoperative improvement in understanding of speech-in-noise and the aided gain from Baha worn on a headband were found to be predictive of the patient's acceptance of surgical implantation of a bone-anchored implant/abutment for Baha. Speech-in-noise testing with and without Baha worn on a headband has a role to play in deciding on the implantation of a bone-anchored hearing solution.
- Published
- 2013
- Full Text
- View/download PDF
36. Association of the Duration of Antibiotic Therapy With Major Surgical Site Infection in Cochlear Implantation
- Author
-
Nicolas Guevara, Eric Truy, Bruno Pereira, Yannick Lerosey, T. Mom, Ruben Hermann, Sonanda Bailleux, B. Baladi, Yohan Gallois, Frédéric Chidiac, Cécile Parietti-Winkler, Olivier Deguine, Benoit Godey, Achraf Sayed-Hassan, Alexis Bozorg-Grayeli, CHU Gabriel Montpied [Clermont-Ferrand], CHU Clermont-Ferrand, Hôpital Edouard Herriot [CHU - HCL], Hospices Civils de Lyon (HCL), Institut Universitaire de la Face et du Cou [Nice], Hôpitaux Pédiatriques de Nice Lenval (CHU-Lenval), Centre Hospitalier Universitaire de Nice (CHU Nice), Hôpital Pierre-Paul Riquet [Toulouse], CHU Toulouse [Toulouse], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Hôpital Charles Nicolle [Rouen], Service d'ORL et de chirurgie maxillo-faciale [Rennes] = ENT Head and Neck Surgery [Rennes], CHU Pontchaillou [Rennes], Service d'Oto-Rhino-Laryngologie et de Chirurgie Cervico-Faciale [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon, Hôpital Purpan [Toulouse], Service d'oto-rhino-laryngologie, Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Université Paris Diderot - Paris 7 (UPD7)-Hôpital Beaujon, Service d'ORL et de chirurgie maxillo-faciale [Rennes], Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-CHU Pontchaillou [Rennes], Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM), Développement, Adaptation et Handicap. Régulations cardio-respiratoires et de la motricité. (DevAH), Université de Lorraine (UL), Unité de biostatistiques, Service ORL, Hôtel-Dieu, and CHU Gabriel Montpied (CHU)
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,medicine.drug_class ,Antibiotics ,Drug Administration Schedule ,Perioperative Care ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Internal medicine ,Humans ,Surgical Wound Infection ,Medicine ,Antibiotic prophylaxis ,Young adult ,Child ,030223 otorhinolaryngology ,Cochlear implantation ,ComputingMilieux_MISCELLANEOUS ,Gram-Positive Bacterial Infections ,Aged ,Retrospective Studies ,Original Investigation ,business.industry ,Infant ,Retrospective cohort study ,Perioperative ,Odds ratio ,Antibiotic Prophylaxis ,Middle Aged ,medicine.disease ,Cochlear Implantation ,Anti-Bacterial Agents ,3. Good health ,Treatment Outcome ,Otorhinolaryngology ,Child, Preschool ,Female ,Surgery ,[INFO.INFO-BI]Computer Science [cs]/Bioinformatics [q-bio.QM] ,Gram-Negative Bacterial Infections ,business ,Meningitis ,030217 neurology & neurosurgery ,Follow-Up Studies - Abstract
International audience; Importance: Infection after cochlear implantation is a rare but serious event that can lead to meningitis. There is no consensus on prevention of infection in these patients, and each center applies its own strategy.Objective: To describe the rates of major surgical site infection for patients undergoing cochlear implantation who receive prolonged antibiotic treatment compared with those who receive a single perioperative dose of antibiotic prophylaxis.Design, setting, and participants: Retrospective cohort study of patients who underwent cochlear implantation between January 1, 2011, and July 8, 2015, with a postoperative follow-up of 1 to 3 years. In this multicenter study at 8 French university centers, 1180 patients (509 children and 671 adults) who underwent cochlear implantation during this period were included.Interventions: Prolonged antibiotic treatment vs single-dose antibiotic prophylaxis.Main outcomes and measures: Major infection and explantation.Results: Among 1180 patients (509 children [51.7% female] with a mean [SD] age of 4.6 [3.8] years and 671 adults [54.9% female] with a mean [SD] age of 54.8 [17.0] years), 12 patients (1.0%) developed a major infection, with 4 infections occurring in the prolonged antibiotic treatment group and 8 infections occurring in the antibiotic prophylaxis group (odds ratio, 2.45; 95% CI, 0.73-8.17). Children (9 of 509 [1.8%]) were more likely to develop infection than adults (3 of 671 [0.4%]). Among children, 4 infections occurred in the prolonged antibiotic group (n = 344), and 5 infections occurred in the antibiotic prophylaxis group (n = 158) (odds ratio, 2.78; 95% CI, 0.74-10.49). Among adults, 3 infections occurred in the antibiotic prophylaxis group (n = 365), whereas no infections occurred in the prolonged antibiotic treatment group (n = 290).Conclusions and relevance: After cochlear implantation, infection was rare, was less common among those who received prolonged antibiotic treatment, and was less likely to occur in adults than in children.
- Published
- 2019
- Full Text
- View/download PDF
37. Atteintes centrales de l'audition
- Author
-
Paul Avan, L Gilain, T Mom, and A. Bascoul
- Subjects
business.industry ,Medicine ,business ,Humanities - Published
- 2010
- Full Text
- View/download PDF
38. L’ischémie cochléaire : des données fondamentales aux espoirs cliniques
- Author
-
Paul Avan, Laurent Gilain, and T. Mom
- Subjects
Gynecology ,medicine.medical_specialty ,Otorhinolaryngology ,business.industry ,medicine ,Surgery ,business - Abstract
Resume Objectifs Exposer les donnees connues des consequences fonctionnelles de l’ischemie cochleaire et les moyens disponibles permettant de les reconnaitre. Methodes Revue des principaux modeles integres in vivo d’ischemie cochleaire decrits chez le mammifere. Resultats Les principaux modeles integres d’ischemie cochleaire utilisent la velocimetrie laser doppler pour quantifier le degre d’ischemie cochleaire. La fonction cochleaire est controlee efficacement par l’analyse au cours de l’ischemie cochleaire des potentiels cochleaires globaux et des otoemissions acoustiques, chacun de ces signaux apportant des informations qui leur sont specifiques. La cochlee s’avere particulierement tolerante a l’ischemie reversible de plusieurs minutes. Le controle indirect de l’ischemie cochleaire par l’analyse des produits de distorsion acoustique est possible au cours d’interventions chirurgicales de l’angle pontocerebelleux. Il est encore impossible de maniere non invasive de detecter directement l’ischemie cochleaire en pratique clinique non chirurgicale. Conclusions Les modeles integres d’ischemie cochleaire ont beaucoup contribue a la connaissance du comportement fonctionnel de la cochlee dans cette situation. Un pas important a franchir en pratique clinique sera de reconnaitre precocement les situations d’ischemie cochleaire de maniere non invasive, par exemple en cas de surdite brusque.
- Published
- 2008
- Full Text
- View/download PDF
39. Trachéopathie ossifiante
- Author
-
B. Liétin, J.-F. Vellin, L. Bivahagumye, O. Aumaître, J.-L. Kemeny, T. Mom, and L. Gilain
- Subjects
Otorhinolaryngology ,Surgery - Published
- 2008
- Full Text
- View/download PDF
40. Exposition professionnelle aux poussières de bois et cancers naso-sinusiens
- Author
-
Laurent Gilain, T. Mom, B. Féneon, L. Fontana, B. Liétin, P. Catilina, C. Devif, and F. Martin
- Subjects
Otorhinolaryngology ,Headache epidemiology ,business.industry ,Medicine ,Surgery ,Occupational exposure ,business ,Humanities - Abstract
Resume Objectifs Determiner les aspects cliniques, histologiques, epidemiologiques et professionnels, en particulier ceux lies a une exposition aux poussieres de bois, d’une serie de 100 tumeurs malignes naso-sinusiennes. Materiel et methodes Il s’agit d’une etude retrospective et descriptive de cas diagnostiques entre le 1er janvier 1981 et le 31 decembre 2000, dans la region Auvergne. Les donnees personnelles, medicales et professionnelles ont ete recueillies a partir de l’interrogatoire du patient, de sa famille lorsqu’il etait decede et des dossiers medicaux disponibles. Resultats Quarante-six cas (46 hommes), d’âge moyen de 63 ± 9,2 ans [43–82] avaient ete exposes aux poussieres de bois dans le cadre du travail avant le diagnostic. Cinquante-quatre cas (30 hommes, 24 femmes), d’âge moyen de 64,3 ± 8,7 ans [40–96] n’avaient jamais ete exposes. L’incidence annuelle moyenne augmente, que ce soit pour la population totale, ou que ce soit pour les deux sous-groupes distingues selon l’exposition professionnelle aux poussieres de bois. La plupart des patients presentaient au moment du diagnostic des signes d’appel multiples. Pour les 46 patients exposes aux poussieres de bois, les tumeurs etaient essentiellement des adenocarcinomes (92 %), avec une localisation ethmoidale. Pour les 54 patients non exposes, les tumeurs observees etaient majoritairement des carcinomes epidermoides (57 %), suivis des adenocarcinomes (15 %). Sur les 46 patients exposes aux poussieres de bois, 85 % avait exerce les metiers de menuisiers ou d’ebenistes. Pour la majorite des patients l’exposition a commence avant 20 ans (âge moyen : 17 ans ± 4,5) et l’essentiel de l’exposition s’est deroulee avant 1981. La duree de l’exposition aux poussieres de bois avant le diagnostic est dans la plupart des cas superieure a 20 ans (duree moyenne : 37 ans ± 11,4). Seuls 15 % etaient encore en activite et exposes au moment du diagnostic (delai moyen entre la fin de l’exposition et le diagnostic : 11 ans ± 2,8). Pour les 54 patients non exposes, aucune profession n’etait particulierement representee. Conclusion Les aspects epidemiologiques, comme l’augmentation de l’incidence, cliniques, professionnels, en particulier sur l’exposition professionnelle aux poussieres de bois de cette serie sont en accord avec la litterature francaise et europeenne. Il est encore probablement trop tot pour juger de l’efficacite des actions de prevention entreprises en France a partir des annees 1980 sur l’incidence de ces tumeurs.
- Published
- 2008
- Full Text
- View/download PDF
41. La régulation pressionnelle du labyrinthe chez l'animal et chez l'homme
- Author
-
P. Avan, T. Mom, and J. Nevoux
- Subjects
Biology - Published
- 2016
- Full Text
- View/download PDF
42. Les thérapeutiques pour la maladie de Menière
- Author
-
Alain Uziel, B. Lassalle-Kinic, V. Darrouzet, Philippe Bordure, X. Dubernard, A. Bazin, André Chays, Cécile Parietti-Winkler, T. Mom, L. Ribeyre, and J.-C. Kleiber
- Subjects
business.industry ,Medicine ,business - Published
- 2016
- Full Text
- View/download PDF
43. Les explorations cliniques et paracliniques pouvant révéler un trouble pressionnel
- Author
-
V. Darrouzet, René Dauman, Fabrice Giraudet, D. Bonnard, T. Mom, P. Avan, V. Franco, I. Djennaoui, D. Bouccara, and J. Nevoux
- Subjects
business.industry ,Medicine ,business - Published
- 2016
- Full Text
- View/download PDF
44. Carcinome adénoïde kystique du méat acoustique externe
- Author
-
Jean Gabrillargues, Laurent Gilain, S. Crestani, O. Nohra, J.-L. Kemeny, J.-F. Vellin, and T. Mom
- Subjects
Gynecology ,medicine.medical_specialty ,Ceruminous gland ,Otorhinolaryngology ,business.industry ,medicine ,Cancer ,Surgery ,business ,medicine.disease - Abstract
Annales Francaises d'Oto-Rhino-Laryngologie et de pathologie cervico-faciale - Vol. 124 - N° 6 - p. 314-317
- Published
- 2007
- Full Text
- View/download PDF
45. Les otoémissions en pratique clinique et chirurgicale
- Author
-
T. Mom
- Subjects
Gynecology ,medicine.medical_specialty ,Otorhinolaryngology ,business.industry ,Medical screening ,medicine ,Surgery ,Professional practice ,business - Abstract
Resume Objectif Les otoemissions acoustiques (OEA) connues depuis 1978 ont une origine endocochleaire bien etablie. Elles dependent etroitement du travail des cellules ciliees externes et servent largement en recherche experimentale pour tester la vitalite cochleaire. Mais les OEA ne sont que tres peu utilisees en pratique clinique, a part pour le depistage des nourrissons. L'objectif de ce dossier thematique est de montrer leur grande utilite clinique. Materiel et methodes Une revue des connaissances physiologiques et biophysiques des OEA, sous leurs differentes formes, provoquees transitoires, ou produits de distorsion acoustiques, precise la nature et l'origine de ce signal acoustique. Differentes situations cliniques sont ensuite exposees et les alterations des OEA expliquees pour chacune. Il est question, notamment du depistage neonatal de la surdite, du diagnostic de surdite en fonction de l'âge, de situations critiques pour la cochlee comme un traitement ototoxique ou une intervention chirurgicale dans l'angle pontocerebelleux. Resultats Les OEA apparaissent potentiellement tres utiles en pratique clinique, notamment pour l'aide au depistage et au diagnostic de surdite. Elles servent aussi a controler l'audition en periode peroperatoire lors de resections tumorales de l'angle pontocerebelleux. Conclusion Les OEA sont encore sous-utilisees par le clinicien dans un but diagnostique alors que leur aide clinique potentielle devrait leur conferer un role primordial.
- Published
- 2007
- Full Text
- View/download PDF
46. [Craniofacial fibrous dysplasia]
- Author
-
A, Couturier, O, Aumaître, T, Mom, L, Gilain, and M, André
- Subjects
Diagnosis, Differential ,Male ,Interleukin-6 ,Skull ,Humans ,Female ,Fibrous Dysplasia, Polyostotic ,Tomography, X-Ray Computed ,Magnetic Resonance Imaging ,Facial Bones - Abstract
Fibrous dysplasia of bone is a benign, uncommon, sporadic, congenital skeletal disorder resulting in deformity. This disease arises from activating somatic mutation in GNAS which encodes the α subunit of the G stimulatory protein associated with proliferation of undifferentiated osteogenic cells resulting in marrow fibrosis, abnormal matrix production, and stimulation of osteoclastic resorption upon overproduction of IL-6 observed in dysplastic cells. Fibrous dysplasia may be monostotic or polyostotic. This mutation affecting many tissues, café au lait skin macules and endocrinopathies (precocious puberty, hyperthyroidism, growth hormone excess, Cushing syndrome) may be associated in McCune-Albright syndrome, but also myxoma in Mazabraud syndrome or phosphate diabetes. Diagnosis of craniofacial fibrous dysplasia should be considered in the presence of headache, neuralgia, sensory disorders (vision, hearing, balance, smelling), functional disorders (nasal obstruction, nasolacrimal duct obstruction, non-matching occlusion), infectious complications (sinusitis, otitis, mastoiditis). Such symptoms should lead to perform craniofacial CT scan completed with MRI. Bone biopsy is not systematic. Surgical treatment is discussed in cases of nervous complication, facial deformity or active lesions. In case of pain resistant to conventional analgesics, intravenous bisphosphonates can be proposed. In non-responder patients, several case reports suggest the efficacy of a monoclonal antibody directed against the IL-6 receptor which requires to be confirmed by randomized studies.
- Published
- 2015
47. Adénocarcinomes de l’ethmoïde : analyse rétrospective des facteurs pronostics
- Author
-
J.-L. Kemeny, J. Chazal, Marc Russier, T. Mom, Laurent Gilain, B. Liétin, Paul Avan, and X. Llompart
- Subjects
Gynecology ,medicine.medical_specialty ,Analisis factorial ,Otorhinolaryngology ,business.industry ,Medicine ,Surgery ,business - Abstract
Objectifs Determiner les differents facteurs pronostiques de survie des adenocarcinomes (ADK) de l’ethmoide Materiel et methodes Soixante patients atteints d’un ADK de l’ethmoide. 59 hommes et une femme. Age moyen de 62,2 ans (41-82). Etude retrospective sur 20 ans. Les donnees suivantes ont ete analysees : duree d’exposition au bois, incidence de la maladie, signes d’appel de la maladie et donnees sur l’etat general du patient (score ASA). Les signes radiologiques recueillis par tomodensitometrie et imagerie par resonance magnetiquenucleaire ont ete analyses. Les caracteristiques histologiques ont ete notees. La classification TNM selon UICC 2002 et selon Roux/Brasnu a ete etablie sur la base des constatations cliniques et radiologiques. Les differents traitements utilises ont ete repertories. L’evaluation des taux de survie et l’impact des differents facteurs pronostiques ont ete realises par la methode de Kaplan-Meier et analyse multivariable. Resultats L’incidence etait de 2,86 nouveaux cas par an. La duree moyenne d’expositiona la poussiere de bois etait de 25,6 ans (2-44). Les tumeurs T3/T4 etaient predominantes (66,7 %). La survie globale brute etait de 46,5 % a 5 ans. La survie etait significativement. Conclusion Les facteurs de survie des ADK de l’ethmoide retrouves dans cette etude sont le stade tumoral et l’envahissement du sinussphenoidal. L’atteinte du sinus sphenoidal devrait, selon cette etude, venir completer les criteres de stadification de l’adenocarcinome de l’ethmoide.
- Published
- 2006
- Full Text
- View/download PDF
48. Tumeurs cervicales et para-pharyngées d’origine osseuse
- Author
-
Jean Gabrillargues, B. Irthum, D. Sinardet, Laurent Gilain, X. Llompart, J.-L. Kemeny, C. Porret, and T. Mom
- Subjects
medicine.anatomical_structure ,Otorhinolaryngology ,business.industry ,medicine ,Surgery ,Aneurysmal bone cyst ,Nuclear medicine ,business ,medicine.disease ,Vertebra - Abstract
Objectif Le but de cette etude etait de rapporter deux cas de tumeurs cervicale et para-pharyngee d’origine osseuse. Materiel et methodes Les patients etaient âges de 29 et 67 ans. Les lesions se presentaient respectivement sous la forme d’une masse cervicale droite et d’une masse para-pharyngee gauche. Les caracteristiques cliniques, radiologiques, anatomo-pathologiques et therapeutiques ont ete analysees de facon retrospective. Resultats Un abord cervical a ete realise dans les deux cas. Les biopsies ont respectivement mis en evidence un kyste anevrysmal osseux primitif vertebral et un chordome corporeo-pediculaire vertebral. Conclusion Les tumeurs osseuses vertebrales revelees par une masse cervicale sont des entites tres rares. Le diagnostic doit etre systematiquement evoque devant une tumeur cervicale ou para-pharyngee associee a une lyse osseuse vertebrale.
- Published
- 2005
- Full Text
- View/download PDF
49. Paragangliomes tympaniques
- Author
-
Jean Gabrillargues, Laurent Gilain, Ph. Thiéblot, J.-L. Kemeny, S. Laurent, and T. Mom
- Subjects
Gynecology ,medicine.medical_specialty ,Otorhinolaryngology ,Tympanic paraganglioma ,business.industry ,medicine ,Surgery ,Ear neoplasm ,business - Abstract
Objectifs Evaluer la prise en charge des patients traites d’un paragangliome tympanique. Patients et methodes De 1996 a 2003, nous avons pris en charge neuf patients porteurs de paragangliomes tympaniques. On comptait 8 femmes et 1 homme (âge moyen : 65 ans). Ces 9 patients furent operes. Cette etude retrospective s’est interessee aux signes revelateurs, aux moyens diagnostiques utilises, a la technique chirurgicale, ainsi qu’aux resultats fonctionnels a court-, moyen-, et long-termes. Resultats L’intervention chirurgicale fut toujours bien supportee. Il n’y eut aucun cas de mastoidite post-operatoire. Aucun patient n’eut de trouble de l’equilibre post-operatoire. La resection tumorale fut obtenue dans 7 cas. Dans un cas, la resection fut incomplete afin de preserver la motricite faciale. Tous les patients sauf un furent soulages de leurs acouphenes apres chirurgie. Toutefois, dans quatre cas, la surdite fut aggravee par la resection chirurgicale, essentiellement par une augmentation de la composante transmissionnelle. Conclusion Le diagnostic de paragangliome tympanique, a evoquer devant tout acouphene pulsatile, est fortement oriente par l’imagerie. Il doit etre le plus precoce possible pour minimiser la morbidite post-operatoire. Si le traitement chirurgical permet la guerison et supprime l’acouphene, il comporte un risque auditif eleve.
- Published
- 2005
- Full Text
- View/download PDF
50. An unusual cause of tracheal stenosis: Diagnosis and management?
- Author
-
C. Darcha, T. Mom, A. Bachy, R. Bellini, Nicolas Saroul, and Laurent Gilain
- Subjects
medicine.medical_specialty ,Otorhinolaryngology ,business.industry ,Computer Science::Computer Vision and Pattern Recognition ,medicine ,ComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISION ,Surgery ,Head and neck ,business ,Tracheal Stenosis - Abstract
European Annals of Otorhinolaryngology, Head and Neck Diseases - Vol. 129 - N° 4 - p. 211-213
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.